Europe Veterinary Medicine Market
Taille du marché en milliards USD
TCAC :
% 
USD
13.18 Billion
USD
21.47 Billion
2024
2032
 Période de prévision |
2025 –2032 |
 Taille du marché (année de référence) |
USD 13.18 Billion |
 Taille du marché (année de prévision) |
USD 21.47 Billion |
 TCAC |
% |
| Principaux acteurs du marché |
|
Marché européen des médicaments vétérinaires, par type (thérapie et diagnostic), application (maladies bactériennes, dermatite atopique canine, infection à Heminthes, cancer animal, fièvre aphteuse, maladies auto-immunes, fièvre catarrhale du mouton, etc.), type d'animal (animaux de compagnie et de rente), utilisateur final (hôpitaux vétérinaires, cliniques vétérinaires, fermes d'élevage, laboratoires de référence, instituts universitaires et de recherche, tests au point de service/tests internes, etc.), canal de distribution (vente au détail, appel d'offres direct, etc.) - Tendances et prévisions du secteur jusqu'en 2032
Analyse du marché européen de la médecine vétérinaire
Le marché européen de la médecine vétérinaire connaît une croissance rapide, portée par l'augmentation du nombre de propriétaires d'animaux de compagnie, la sensibilisation croissante à la santé animale et les progrès des soins vétérinaires. La demande de traitements spécialisés, de vaccins, d'antibiotiques et d'anti-inflammatoires augmente, parallèlement au besoin d'améliorer la prévention et la gestion des maladies, tant chez les animaux de compagnie que chez les animaux d'élevage. Les avancées technologiques, telles que les produits biologiques et les outils de diagnostic numérique, améliorent encore les options thérapeutiques. De plus, la prévalence croissante des zoonoses et l'accent mis sur les soins préventifs contribuent à la croissance du marché. Avec la hausse des dépenses consacrées aux soins de santé des animaux de compagnie et à la gestion du bétail, le marché de la médecine vétérinaire est promis à une expansion soutenue.
Taille du marché européen de la médecine vétérinaire
Le marché européen des médicaments vétérinaires devrait atteindre 21,47 milliards USD d'ici 2032, contre 13,18 milliards USD en 2024, avec un TCAC de 6,3 % au cours de la période de prévision de 2025 à 2032. Outre les informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse des importations et des exportations, un aperçu de la capacité de production, une analyse de la consommation de production, une analyse des tendances des prix, un scénario de changement climatique, une analyse de la chaîne d'approvisionnement, une analyse de la chaîne de valeur, un aperçu des matières premières/consommables, des critères de sélection des fournisseurs, une analyse PESTLE, une analyse Porter et un cadre réglementaire.
Tendances du marché européen de la médecine vétérinaire
« Augmentation du nombre d'animaux de compagnie et progrès »
Le marché européen des médicaments vétérinaires connaît une croissance significative, portée par l'augmentation du nombre d'animaux de compagnie, la sensibilisation croissante à la santé animale et les progrès des soins vétérinaires. Le marché évolue vers des traitements plus spécialisés, tant pour les animaux de compagnie que pour le bétail. La demande croissante de vaccins, d'antibiotiques et d'anti-inflammatoires entraîne des innovations dans les formulations médicamenteuses, contribuant ainsi à une meilleure prévention et gestion des maladies. L'adoption croissante de pratiques de soins préventifs, telles que les vaccinations de routine et les bilans de santé, stimule également le marché. Par ailleurs, la recrudescence des zoonoses et la nécessité d'améliorer le contrôle des maladies en élevage stimulent la demande de médicaments vétérinaires.
Portée du rapport et segmentation du marché européen de la médecine vétérinaire
|
Attributs |
Aperçu du marché européen de la médecine vétérinaire |
|
Segments couverts |
|
|
Région couverte |
États-Unis, Canada, Mexique, Allemagne, France, Royaume-Uni, Italie, Espagne, Russie, Pays-Bas, Suisse, Turquie, Belgique, Suède, Danemark, Finlande, Norvège, Pologne, reste de l'Europe, Japon, Chine, Inde, Corée du Sud, Australie, Singapour, Thaïlande, Malaisie, Indonésie, Vietnam, Philippines, Taïwan, Nouvelle-Zélande, reste de l'Asie-Pacifique, Brésil, Argentine, reste de l'Amérique du Sud, Afrique du Sud, Arabie saoudite, Émirats arabes unis, Égypte, Koweït, Israël, Qatar, Oman, Bahreïn et reste du Moyen-Orient et de l'Afrique |
|
Principaux acteurs du marché |
Zoetis Services LLC (États-Unis), Merck & Co., Inc. (États-Unis), Elanco ou ses filiales. (États-Unis), CH Boehringer Ingelheim International GmbH et IDEXX LABORATORIES, INC (Allemagne), AB Science (France), AdvaCare Pharma (États-Unis), ALMAX IMAGING srl (Italie), Anivive (États-Unis), BIOMÉRIEUX (France), Bionote USA Inc. (États-Unis), Bio-Rad Laboratories (États-Unis), Inc., CANON MEDICAL SYSTEMS EUROPE BV (Japon), Cargill, Incorporated (États-Unis), Ceva (France), CureLab Oncology (États-Unis), Dechra Pharmaceuticals Limited (Royaume-Uni), Demeditec Diagnostics GmbH (Allemagne), DHN International (États-Unis), Diagnostic Imaging Systems (États-Unis), ESAOTE SPA (Italie), Eurofins Scientific (Luxembourg), Evonik Industries AG (Allemagne), FUJIFILM Holdings Corporation (Japon), Gold Standard Diagnostics (États-Unis), Hallmarq Veterinary Imaging (Royaume-Uni), Hebei Veyong pharmaceutical Co., Ltd. (Chine), Heska Corporation (États-Unis), IBIS SRL (Italie), Karyopharm (États-Unis), Meridian Bioscience, Inc. (États-Unis), Narang Medical Limited (Inde), Neogen Corporation (États-Unis), NIPPON ZENYAKU KOGYO CO., LTD. (Japon), Novavive Inc. (États-Unis), Nutreco (Pays-Bas), PLANMECA OY (Finlande), RINGPU BIOLOGY Co., Ltd. (Chine), Shenzhen SONTU Medical Imaging Equipment Co., Ltd (Chine), Thermo Fisher Scientific Inc. (États-Unis), Torigen Pharmaceuticals Inc. (États-Unis), VetDC (États-Unis), Vetoquinol (France), Virbac (France), VMRD, Inc. (États-Unis) |
|
Opportunités de marché |
|
|
Ensembles d'informations de données à valeur ajoutée |
Outre les informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse des importations et des exportations, un aperçu de la capacité de production, une analyse de la consommation de production, une analyse des tendances des prix, un scénario de changement climatique, une analyse de la chaîne d'approvisionnement, une analyse de la chaîne de valeur, un aperçu des matières premières/consommables, des critères de sélection des fournisseurs, une analyse PESTLE, une analyse Porter et un cadre réglementaire. |
Définition du marché européen de la médecine vétérinaire
Le marché européen de la médecine vétérinaire englobe le développement, la production et la distribution de produits pharmaceutiques, de vaccins, de diagnostics et de dispositifs médicaux destinés à prévenir, diagnostiquer et traiter les maladies animales. Il s'adresse aussi bien aux animaux de compagnie qu'aux animaux d'élevage (bovins, volailles et porcs). Ce marché est stimulé par des facteurs tels que l'augmentation du nombre d'animaux de compagnie, la demande d'aliments d'origine animale, la sensibilisation accrue à la santé animale et les avancées technologiques. Il comprend des produits tels que les médicaments, les vaccins et les antiparasitaires, dont la croissance est alimentée par les innovations en biotechnologie, les normes réglementaires et l'attention portée à la sécurité alimentaire, à la qualité et au bien-être animal à l'échelle mondiale.
Dynamique du marché européen des médicaments vétérinaires
Conducteurs
- L'augmentation du nombre d'animaux de compagnie stimule la demande de services vétérinaires
Le marché européen de la médecine vétérinaire a connu une croissance significative ces dernières années, portée par l'augmentation du nombre d'animaux de compagnie et une sensibilisation croissante aux soins animaliers. L'accueil de plus en plus fréquent d'animaux de compagnie par les particuliers et les familles s'accompagne d'une prise de conscience accrue de la nécessité de services vétérinaires professionnels pour assurer leur santé et leur bien-être. Les propriétaires d'animaux sont de plus en plus conscients de l'importance des contrôles vétérinaires réguliers, des soins préventifs, des vaccinations et du dépistage précoce des maladies, ce qui entraîne une forte demande de médicaments et de traitements vétérinaires. De plus, cette sensibilisation accrue aux soins de santé animale a favorisé l'acceptation et l'adoption d'outils de diagnostic avancés, d'interventions thérapeutiques et de traitements spécialisés qui améliorent la qualité de vie des animaux. Cette prise de conscience croissante s'étend au-delà des animaux de compagnie traditionnels comme les chiens et les chats, puisque la possession d'animaux comprend désormais des animaux exotiques, des oiseaux et d'autres espèces, diversifiant ainsi davantage le marché de la médecine vétérinaire. L'augmentation du revenu disponible, notamment dans les économies émergentes, a permis à un plus grand nombre de propriétaires d'animaux de compagnie de se permettre des soins vétérinaires et d'en faire une priorité, alimentant ainsi la croissance du marché. L'expansion du marché de l'assurance pour animaux de compagnie contribue également à stimuler la demande de médicaments vétérinaires, les propriétaires cherchant à protéger leurs animaux contre les dépenses médicales imprévues. De plus, l'essor du commerce électronique et des consultations vétérinaires en ligne a facilité l'accès aux produits vétérinaires, créant ainsi un marché européen plus vaste pour les médicaments vétérinaires, qu'ils soient sur ordonnance ou en vente libre. L'augmentation du nombre d'animaux de compagnie, la sensibilisation accrue à la santé animale et les progrès de la médecine vétérinaire ont créé un marché dynamique et en pleine évolution, positionnant la médecine vétérinaire comme un segment clé du secteur de la santé.
Par exemple,
- Selon un article publié en septembre 2021 par ReserchGate, la croissance du secteur indien des animaux de compagnie est alimentée par une sensibilisation croissante aux soins des animaux, des changements de mode de vie et une hausse des revenus. Les propriétaires d'animaux, qui les considèrent comme des membres de leur famille, investissent dans la santé, l'alimentation et les accessoires. Des facteurs tels que l'urbanisation, l'humanisation des animaux et l'évolution des préférences des consommateurs stimulent cette croissance, entraînant une augmentation du nombre de propriétaires d'animaux et une sensibilisation accrue à leur égard.
- En mai 2023, selon l'article publié par le Times of India, la sensibilisation croissante de l'Inde au bien-être animal est motivée par la loi de 1960 sur la prévention de la cruauté envers les animaux et par des initiatives comme le programme de contrôle des naissances animales. Les ONG, telles que People for Animals et la Blue Cross of India, promeuvent activement la protection des animaux, les efforts de sauvetage et l'éducation, favorisant une plus grande sensibilisation à la possession et aux soins des animaux de compagnie.
En conclusion, le marché européen de la médecine vétérinaire a connu une croissance substantielle, largement tirée par la tendance croissante à posséder des animaux de compagnie et par une sensibilisation accrue aux soins animaliers. L'adoption croissante d'animaux de compagnie a accru la prise de conscience du besoin crucial de services vétérinaires professionnels, ce qui a entraîné une forte demande de médicaments, de traitements et de soins préventifs vétérinaires. Cette évolution vers une santé animale proactive a également stimulé l'adoption d'outils de diagnostic avancés et de traitements spécialisés, bénéficiant à un plus large éventail d'animaux de compagnie, notamment les animaux exotiques et les oiseaux. La croissance du revenu disponible dans les économies émergentes et l'expansion du marché de l'assurance pour animaux de compagnie contribuent également à cette croissance, permettant aux propriétaires d'animaux de donner la priorité aux soins de santé de leurs compagnons. De plus, l'essor du commerce électronique et des consultations en ligne a amélioré l'accessibilité aux produits vétérinaires, élargissant le marché des médicaments sur ordonnance et en vente libre. En fin de compte, l'attention croissante portée à la santé des animaux de compagnie, conjuguée aux progrès constants de la médecine vétérinaire, a positionné ce secteur comme un acteur clé du secteur de la santé au sens large.
- L'augmentation des maladies animales entraîne un besoin de soins vétérinaires avancés
L'augmentation des maladies animales, notamment infectieuses et chroniques, est devenue un moteur de croissance important du marché européen de la médecine vétérinaire. Alors que des maladies comme le parvovirus canin, la leucémie féline et les zoonoses émergentes comme la grippe aviaire et la grippe porcine continuent de toucher les animaux domestiques et d'élevage, la demande de traitements vétérinaires et de mesures préventives augmente. La prévalence croissante de maladies chroniques comme l'arthrite, le diabète et l'obésité chez les animaux de compagnie, conjuguée à la multiplication des épidémies de maladies infectieuses, a souligné l'importance du dépistage précoce, de la vaccination et d'une prise en charge continue, accentuant ainsi le besoin de soins vétérinaires avancés. De plus, l'augmentation des maladies a mis davantage l'accent sur les mesures de biosécurité, les tests diagnostiques et le développement de nouveaux vaccins et traitements, entraînant une augmentation des innovations pharmaceutiques vétérinaires. Avec l'augmentation de la population animale en Europe, notamment dans les zones urbaines densément peuplées, la propagation des maladies devient plus probable, ce qui nécessite le développement et le déploiement continus de médicaments vétérinaires pour atténuer les risques sanitaires. La fréquence croissante des épidémies, conjuguée à une sensibilisation accrue du public à l'importance de la santé animale, a stimulé les investissements en recherche et développement, permettant ainsi à la médecine vétérinaire de répondre à un large éventail de défis en matière de santé animale. Par conséquent, la demande de produits vétérinaires – des antibiotiques et antiviraux aux vaccins et aux nutraceutiques – devrait continuer de croître, consolidant ainsi le marché de la médecine vétérinaire comme un segment essentiel du secteur de la santé en Europe.
Par exemple,
- En juin 2022, selon un article publié par le NCBI, les zoonoses, responsables de millions de maladies et de décès humains chaque année, présentent des risques importants pour la santé publique, comme l'a montré la pandémie de SRAS-CoV-2. Ces maladies ont un impact sur la santé humaine, animale et environnementale, causant des dommages économiques (coûts de santé, pertes de production animale et perturbations des écosystèmes), ce qui souligne la nécessité de stratégies de prévention efficaces.
- En juin 2021, selon un article publié par l'Indian Journal of Medical Research, l'intensification des contacts humains-animaux, due à la déforestation, à la demande de produits issus de la faune sauvage et aux pratiques agricoles, favorise l'émergence de zoonoses comme la COVID-19. Ces épidémies entraînent d'importantes pertes sanitaires et économiques. L'insuffisance des systèmes de santé publique et le manque d'approches interdisciplinaires soulignent la nécessité de politiques globales axées sur la protection de la faune sauvage, l'aménagement du territoire et la prévention des maladies.
L'augmentation des maladies animales, tant infectieuses que chroniques, stimule considérablement la croissance du marché européen de la médecine vétérinaire. Des maladies comme le parvovirus canin, la leucémie féline et les zoonoses émergentes accroissent la demande de traitements vétérinaires et de soins préventifs. Les maladies chroniques comme l'arthrite et le diabète sont également plus fréquentes, ce qui nécessite une prise en charge continue et un dépistage précoce. Cela a conduit à des investissements accrus dans la biosécurité, les tests diagnostiques, les vaccins et les traitements. Face à la fréquence croissante des épidémies, notamment en zone urbaine, la demande de médicaments vétérinaires continue d'augmenter, faisant des soins vétérinaires un segment essentiel des soins de santé en Europe.
Opportunités
- L'augmentation du nombre d'animaux entraîne une demande accrue de médecine vétérinaire
L'augmentation du nombre d'animaux, notamment dans le secteur de l'élevage, offre une opportunité significative pour le marché européen de la médecine vétérinaire. Face à la croissance démographique européenne et à la demande croissante de viande, de produits laitiers et d'autres produits animaux, il est urgent de disposer d'un bétail performant, productif et en bonne santé. Alors que les éleveurs s'efforcent d'optimiser leur productivité et de garantir le bien-être animal, la demande de services et de produits vétérinaires tels que les vaccins, les antibiotiques et les compléments alimentaires est appelée à augmenter. Cette croissance est également alimentée par la nécessité de prévenir les épidémies et de garantir la sécurité alimentaire, deux éléments essentiels au maintien de la santé publique et animale. Par conséquent, face à la croissance continue du nombre d'animaux d'élevage, la médecine vétérinaire jouera un rôle crucial dans le soutien de ce secteur.
Par exemple,
- En mars 2021, selon un article publié dans Frontiers in Veterinary Science, on comptait environ un milliard de chèvres dans le monde, et la population caprine européenne a plus que doublé au cours des quatre dernières décennies. Selon l'Organisation des Nations Unies pour l'alimentation et l'agriculture, plus de 90 % des chèvres vivent dans les pays en développement ; l'Asie abrite la plus grande proportion de la population caprine mondiale, suivie de l'Afrique.
De plus, les progrès des pratiques agricoles et l'évolution vers des systèmes d'élevage intensif créent de nouvelles opportunités sur le marché de la médecine vétérinaire. À mesure que les exploitations agricoles s'agrandissent et se complexifient, les stratégies de gestion sanitaire nécessaires au maintien de normes élevées de bien-être animal et de biosécurité deviennent de plus en plus sophistiquées. Ces progrès ouvrent la voie à des technologies vétérinaires innovantes, notamment des outils de diagnostic et des systèmes de surveillance sanitaire qui aident les éleveurs à identifier et à atténuer rapidement les risques sanitaires. De plus, l'importance croissante accordée aux pratiques agricoles durables et à l'utilisation responsable des médicaments favorise le développement de produits vétérinaires plus ciblés et plus respectueux de l'environnement. Cette adéquation de la médecine vétérinaire à l'évolution des pratiques agricoles crée un terreau fertile pour la croissance, l'innovation et la collaboration entre vétérinaires, éleveurs et laboratoires pharmaceutiques.
- Croissance de la biotechnologie en santé animale
La croissance des biotechnologies en santé animale représente une opportunité majeure pour le marché européen de la médecine vétérinaire, facilitant le développement de solutions innovantes et ciblées pour la gestion de la santé animale. Les avancées en biotechnologie, telles que le génie génétique, la thérapie génique et l'immunologie, permettent la création de vaccins adaptés à des maladies spécifiques, améliorant ainsi leur efficacité et leur sécurité. Cette évolution vers les approches biotechnologiques répond aux préoccupations croissantes concernant la résistance aux antibiotiques chez les animaux d'élevage, car les biotechnologies peuvent conduire au développement d'alternatives aux antibiotiques traditionnels, garantissant ainsi des animaux en meilleure santé et améliorant la sécurité alimentaire. Face à la demande croissante de produits animaux plus sûrs et de meilleure qualité, l'application des biotechnologies en médecine vétérinaire peut répondre à ces attentes tout en favorisant des pratiques agricoles plus durables.
Par exemple,
- En septembre 2023, selon un article publié par ResearchGate, la biotechnologie animale représente un domaine de pointe qui a révolutionné nos interactions avec le règne animal. Les avancées récentes couvrent divers domaines, notamment les techniques d'édition génétique comme CRISPR-Cas9, qui permettent des modifications génétiques précises pour améliorer la santé animale et la qualité des produits.
- En août 2024, selon un article publié par l'Institut national de l'alimentation et de l'agriculture, les avancées en biotechnologie animale ont été facilitées par les progrès récents dans le séquençage des génomes animaux, l'expression des gènes et le profilage métabolique des cellules animales. Plus récemment, les technologies d'édition génomique (nucléases à doigts de zinc, TALENS et systèmes CRISPR-Cas) ont ouvert de nouvelles perspectives pour créer facilement des variations génétiques chez les animaux, améliorant ainsi leur santé et leur bien-être, leur production agricole et leur protection contre les maladies.
De plus, l'intégration des biotechnologies en santé animale favorise l'amélioration des diagnostics et des traitements, susceptibles d'améliorer le bien-être et la productivité des animaux. Les outils issus des avancées biotechnologiques, tels que le diagnostic moléculaire et l'identification de biomarqueurs, permettent une détection et un suivi plus précis des maladies, permettant aux vétérinaires de mettre en œuvre des interventions rapides. Cela profite non seulement à la santé des animaux, mais réduit également les pertes économiques pour les éleveurs dues aux épidémies et à une productivité sous-optimale. L'importance croissante accordée à la médecine vétérinaire de précision – exploitant les données pour adapter les interventions – amplifie encore la demande d'innovations biotechnologiques. Par conséquent, les acteurs du marché européen des médicaments vétérinaires – notamment les laboratoires pharmaceutiques, les chercheurs et les développeurs de technologies – ont tout à gagner à investir dans les biotechnologies de la santé animale et à exploiter leur potentiel pour améliorer les résultats pour les animaux et le secteur agricole dans son ensemble.
Contraintes/Défis
- Les coûts élevés des soins vétérinaires limitent l'accessibilité au marché
Le coût élevé des soins vétérinaires constitue un frein important à l'accès au marché, impactant directement les propriétaires d'animaux de compagnie et les éleveurs européens. Pour les propriétaires d'animaux, les dépenses liées aux diagnostics avancés, aux interventions chirurgicales et aux soins spécialisés entraînent souvent des décisions difficiles en matière de santé, nombre d'entre eux optant pour des solutions économiques ou retardant les traitements nécessaires pour leurs animaux. Cela a entraîné une demande croissante d'alternatives abordables telles que les médicaments sans ordonnance, les traitements préventifs et les vaccins. De plus, l'assurance pour animaux de compagnie est devenue une option plus populaire pour compenser le fardeau financier des services vétérinaires. Parallèlement, les éleveurs, notamment dans les économies en développement, sont confrontés à des contraintes financières qui entravent leur accès à l'ensemble des soins vétérinaires nécessaires au maintien d'une santé animale optimale. Cette limitation affecte la qualité des soins qu'ils peuvent prodiguer à leurs animaux, ce qui entraîne un besoin accru de solutions plus économiques comme les médicaments génériques, les nutraceutiques et les vaccins pour la prévention des maladies. Ces coûts élevés stimulent également l'innovation au sein du secteur vétérinaire, les entreprises cherchant à développer des traitements abordables sans sacrifier la qualité. Par ailleurs, à mesure que les soins vétérinaires se spécialisent et s'appuient sur des technologies de pointe, l'accent est mis sur la rationalisation des services et la mise en œuvre de modèles de soins préventifs. Ces modèles visent à réduire les coûts à long terme pour les propriétaires d'animaux de compagnie et les producteurs agricoles, soulignant l'importance de la rentabilité pour façonner l'évolution du marché de la médecine vétérinaire. Malgré ces efforts, le coût élevé des services vétérinaires demeure un obstacle majeur, limitant l'accessibilité et influençant la trajectoire de croissance du marché.
Par exemple,
- En juillet 2024, selon un article publié par le NCBI, les coûts des interventions vétérinaires, telles que les interventions vétérinaires pour chiens et chats, ont connu des hausses significatives entre l'automne 2022 et l'hiver 2023/2024, avec des prix en hausse de 2 à 24 %. Les interventions chirurgicales d'urgence et les interventions vétérinaires pour chevaux ont également connu de fortes hausses de coûts, soulignant le poids financier des soins vétérinaires, avec des variations de prix importantes selon les pays et les interventions.
- En juillet 2020, selon un article publié par le NCBI, malgré la popularité croissante des chiens, les visites chez le vétérinaire ont diminué, tandis que le coût moyen par consultation est passé de 138 à 161 dollars. L'augmentation des coûts de main-d'œuvre, des fournitures et des équipements médicaux contribue à cette hausse des dépenses. L'assurance maladie pour animaux de compagnie augmente également les dépenses vétérinaires, ce qui impacte le coût global des soins pour les propriétaires.
En conclusion, le coût élevé des soins vétérinaires est un facteur déterminant sur le marché européen de la médecine vétérinaire, incitant les propriétaires d'animaux de compagnie et les éleveurs à rechercher des solutions plus abordables et accessibles. Cela a entraîné une demande croissante de produits rentables tels que les vaccins, les traitements préventifs et les génériques. De plus, ces coûts élevés encouragent l'innovation au sein du secteur, l'accent étant mis sur le développement de traitements abordables et de qualité, ainsi que sur la rationalisation des services. Alors que les propriétaires d'animaux de compagnie et d'animaux de compagnie cherchent à maîtriser leurs dépenses, la demande de soins vétérinaires économiques continuera de façonner la croissance et l'évolution du marché de la médecine vétérinaire.
- Défis de conformité réglementaire et complexité
Les questions réglementaires et de conformité constituent des défis majeurs sur le marché européen des médicaments vétérinaires, en raison des exigences complexes et spécifiques à chaque région auxquelles les entreprises doivent se conformer pour garantir que leurs produits répondent aux normes de sécurité et sont approuvés. Les organismes de réglementation varient selon les pays et les régions, chacun disposant de ses propres directives pour l'approbation des médicaments vétérinaires. Par exemple, aux États-Unis, la Food and Drug Administration (FDA) est chargée de garantir la sécurité et l'efficacité des produits vétérinaires, tandis que dans l'Union européenne, c'est l'Agence européenne des médicaments (EMA) qui réglemente ces produits. Ces organismes de réglementation ont souvent des processus d'approbation rigoureux et chronophages, comprenant des tests approfondis, une documentation et des examens périodiques, ce qui peut retarder le lancement de nouveaux médicaments vétérinaires.
De plus, l'attention croissante portée au bien-être animal et à la sécurité environnementale a introduit des niveaux de complexité supplémentaires. Le respect de ces réglementations exige souvent des fabricants qu'ils mènent des recherches plus approfondies, notamment des tests sur les animaux et des évaluations de sécurité à long terme, ce qui peut s'avérer coûteux et chronophage. Dans certains pays, les réglementations peuvent être plus strictes ou moins transparentes, ce qui crée des incertitudes et ralentit l'entrée sur le marché. Les entreprises doivent également adapter leurs produits aux différents cadres réglementaires des différents marchés, ce qui peut complexifier davantage la distribution des produits et augmenter les coûts opérationnels.
Par exemple,
- En juillet 2024, selon un communiqué publié par le groupe Rebexa, la gestion des diverses exigences réglementaires selon les régions pose des défis majeurs au marché européen des médicaments vétérinaires. La diversité des processus d'approbation, des normes de sécurité et des réglementations en matière de bien-être animal augmente les coûts et retarde le lancement des produits. L'émergence de nouvelles préoccupations, comme la résistance aux antimicrobiens, entraîne une évolution des directives, compliquant encore davantage la conformité et freinant le potentiel de croissance du marché.
- En juillet 2021, un article publié par ScienceDriect soulignait la complexité de la réglementation européenne en matière de médicaments vétérinaires, soulignant que chaque pays, comme les États-Unis, l'UE et l'Australie, appliquait des processus d'approbation et des normes de sécurité différents. L'absence de cadres unifiés pour les zoonoses, la constitution de stocks de médicaments vétérinaires et la mise en place de centres de pharmacovigilance dans de nombreux pays complique encore les choses, entravant le développement du marché et la cohérence des soins vétérinaires en Europe.
Les défis réglementaires et de conformité créent d'importants obstacles à l'entrée sur le marché des médicaments vétérinaires, retardent la disponibilité des produits et augmentent les coûts pour les entreprises. La suppression de ces obstacles par la simplification des processus et l'harmonisation réglementaire internationale pourrait alléger la pression, permettant un accès plus rapide au marché, une meilleure adéquation avec les besoins en matière de santé animale et, in fine, une amélioration du bien-être animal à l'échelle mondiale.
Portée du marché européen de la médecine vétérinaire
Le marché européen des médicaments vétérinaires est segmenté en cinq segments distincts, selon le type, l'application, le type d'animal, l'utilisateur final et le canal de distribution. La croissance de ces segments vous permettra d'analyser les segments à faible croissance du secteur et de fournir aux utilisateurs une vue d'ensemble et des informations précieuses sur le marché, facilitant ainsi la prise de décisions stratégiques pour identifier les applications clés du marché.
Taper
- Thérapeutique
- Médicaments
- Antibiotiques
- Tétracycline
- Pénicillines
- Macrolides
- Aminoglycosides
- Lincosamides
- colistine
- Autres
- Parasiticides
- Benzimidazoles
- Lactones macrocycliques
- Pyréthroïdes
- Amprolium
- Nitroimidazoles
- Pipérazine
- Autres
- Anlagesiques/Anti-inflammatoires (AINS)
- Carprofène
- Méloxicam
- Phénylbutazone
- Acétaminophène
- Firocoxib
- Déracoxib
- Autres
- Antihistaminiques
- Cétirizine
- Bromphéniramine
- Diphenhydramine
- Terfénadine
- Triméprazine
- Autres
- Corticostéroïdes
- Dexaméthasone
- Prednisolone
- Prednisone
- Autres
- Antiballonnement
- Docusate
- Siméthicone
- Autres
- Hormonal
- Gonadotrophine chorionique équine
- Cloprosténol
- L'ocytocine
- Autres
- Antibiotiques
- Opioïdes
- Agonistes Mu
- Méthadone
- mépéridine
- Morphine
- Oxymorphone
- Autres
- Agoniste Mu partiel
- Buprénorphine
- Autres
- Agoniste Kappa-Agoniste Mu
- Butorphanol
- Autres
- Agonistes Mu
- Autres
- De marque
- Générique
- Sur ordonnance
- Sur le comptoir
- Oral
- Comprimés
- Solutions
- Poudre
- Autres
- Parental
- intraveineuse
- Sous-cutané
- Autres
- Topique
- Autres
- Médicaments
- Vaccins
- Vaccins vivants atténués
- Vaccins à base d'anatoxines
- Vaccins recombinants
- vaccins inactivés
- Autres
- Produits biologiques
- Commercialisé
- Tocéranib
- Lomustine
- Cyclophosphamide
- Chlorambucil
- Autres
- Émergent
- Commercialisé
- Additifs alimentaires médicamenteux
- Enzymes
- Phytase
- Carbohydrase
- Protéase
- Amylase
- Cellulase
- Mannase
- Glucanase
- Xylanase
- Autres
- Enzymes
- Acide aminé
- Lysine
- Méthionine
- Thréonine
- tryptophane
- Autres
- Vitamines
- Vitamine liposoluble
- Vitamine A
- Vitamine E
- Vitamine D
- Vitamine K
- Vitamine hydrosoluble
- Complexe de vitamines B
- Vitamine C
- Vitamine liposoluble
- Antioxydants
- Bha
- Bht
- Éthoxyquine
- Autres
- Probiotiques
- Lactobacilles
- Bifidobactéries
- Levure
- Stretococcus Thermophilus
- Acidifiants alimentaires
- acide propionique
- acide formique
- Acide lactique
- Acide citrique
- Autres
- Détoxifiants des mycotoxines
- Liants de mycotoxines
- Silicates
- Argiles
- polymères chimiques
- Produits à base de glucane
- Autres
- Modificateurs de mycotoxines
- Liants de mycotoxines
- Phytogène
- Huiles essentielles
- Herbes et épices
- Oléorésine
- Autres
- caroténoïdes
- Bêta-carotène
- Astaxanthine
- Lutéine
- Canthaxanthine
- oligo-éléments
- Zinc
- Cuivre
- Manganèse
- Fer
- Sélénium
- Autres
- Conservateurs
- Agents antiagglomérants
- Inhibiteurs de moisissures
- Arômes et édulcorants
- Saveurs
- Édulcorants
- Saccharine
- dihydrochalcone de néohespéridine
- Glycyrrhizine
- Thaumatine
- Autres
- Autres
- Diagnostic
- Instruments et appareils
- Dispositifs d'imagerie
- Imagerie radiographique (radiographie)
- Petits animaux
- Grands animaux
- Ultrason
- Petits animaux
- Grands animaux
- tomodensitométrie
- Petits animaux
- Grands animaux
- Imagerie par résonance magnétique
- Petits animaux
- Grands animaux
- Tomographie par émission monophotonique (Spect)
- Petits animaux
- Grands animaux
- Autres
- Imagerie radiographique (radiographie)
- Dispositifs d'imagerie
- Instruments et appareils
- Instruments de laboratoire
- Analyseurs d'hématologie
- Automatique
- Semi-automatique
- Gamme de prix élevée
- Gamme de prix standard
- Paillasse
- Portable
- Autres
- Analyseurs de chimie
- Automatique
- Semi-automatique
- Paillasse
- Portable
- Sang
- Urine
- Tabouret
- Autres
- Instruments de point de service
- Poct à flux latéral
- Poct moléculaire
- Autres
- Analyseurs de coagulation
- Automatique
- Semi-automatique
- 4 canaux
- 1 canal
- Sang total
- Plasma
- Paillasse
- Portable
- Équipement d'analyse d'urine
- Automatique
- Semi-automatique
- Réfractomètre
- Optique
- Numérique
- Paillasse
- Portable
- Autres
- Analyseurs d'hématologie
- Réactifs et consommables
- Kits
- Kits PCR
- Kits de tests rapides
- Kits multiplexés
- Kits Elisa
- Kits de préparation d'échantillons Kits d'isolement et d'extraction
- Autres
- Réactifs
- Réactifs d'extraction d'acide nucléique
- Réactifs d'immunofluorescence
- Réactifs de Coombs
- Autres réactifs
- Kits
- Médias
- Panneau
- Bandes
- Cassette
- Normes de contrôle
- Sondes et amorces
- Autres consommables et accessoires
Application
- Maladies bactériennes
- Animaux de production
- Animaux de compagnie
- Dermatite atopique canine
- Animaux de compagnie
- Animaux de production
- Infection à Heminthes
- Animaux de production
- Animaux de compagnie
- Cancer animal
- Animaux de compagnie
- Animaux de production
- Fièvre aphteuse
- Animaux de production
- Animaux de compagnie
- Maladies auto-immunes
- Animaux de compagnie
- Animaux de production
- Fièvre catarrhale
- Animaux de production
- Animaux de compagnie
- Autres
- Animaux de compagnie
- Animaux de production
Type d'animal
- Animaux de compagnie
- Chiens
- Chats
- Chevaux
- Autres
- Animaux de production
- Volaille
- Bétail
- Porc
- Poisson
- Moutons et chèvres
- Autres
Utilisateur final
- hôpitaux vétérinaires
- Privé
- Publique
- Niveau 2
- Niveau 1
- Niveau 3
- Cliniques vétérinaires
- Publique
- Privé
- Fermes animales et vétérinaires
- Laboratoires de référence
- Institut universitaire et de recherche
- Tests au point de service/Tests en interne
- Autres
Canal de distribution
- Ventes au détail
- Hors ligne
- Pharmacie de l'hôpital
- Pharmacie de détail
- En ligne
- Plateformes de commerce électronique
- Site Web de l'entreprise
- Autres
- Hors ligne
- Appel d'offres direct
- Autres
Analyse régionale du marché européen des médicaments vétérinaires
Le marché est analysé et des informations sur la taille et les tendances du marché sont fournies en fonction du pays, du type, de l'application, du type d'animal, de l'utilisateur final et du canal de distribution, comme indiqué ci-dessus.
Les pays couverts sur le marché sont les États-Unis, le Canada, le Mexique, l'Allemagne, la France, le Royaume-Uni, les Pays-Bas, la Suisse, la Belgique, la Russie, l'Italie, l'Espagne, la Turquie, le reste de l'Europe, la Chine, le Japon, l'Inde, la Corée du Sud, Singapour, la Malaisie, l'Australie, la Thaïlande, l'Indonésie, les Philippines, le reste de l'Asie-Pacifique, l'Arabie saoudite, les Émirats arabes unis, l'Afrique du Sud, l'Égypte, Israël, le reste du Moyen-Orient et de l'Afrique, le Brésil, l'Argentine et le reste de l'Amérique du Sud.
L'Amérique du Nord devrait dominer le marché européen de la médecine vétérinaire grâce à ses infrastructures de santé avancées, à l'adoption croissante des animaux de compagnie, à l'essor de l'élevage, à d'importants investissements en R&D et à des politiques gouvernementales favorables. La robustesse de l'industrie pharmaceutique de la région, la sensibilisation croissante à la santé animale et les dépenses vétérinaires élevées stimulent la croissance et l'innovation du marché.
L'Asie-Pacifique devrait connaître la croissance la plus rapide sur le marché européen de la médecine vétérinaire, en raison de l'urbanisation rapide, de l'augmentation du nombre d'animaux de compagnie, de l'augmentation de la production animale et de la sensibilisation croissante à la santé animale. Le développement des infrastructures vétérinaires, le soutien gouvernemental, les progrès des biotechnologies et l'augmentation du revenu disponible stimulent la croissance du marché, faisant de la région un acteur clé de la médecine vétérinaire.
La section pays du rapport présente également les facteurs d'impact sur les marchés individuels et les évolutions réglementaires nationales qui influencent les tendances actuelles et futures du marché. Des données telles que l'analyse des chaînes de valeur en aval et en amont, les tendances techniques, l'analyse des cinq forces de Porter et les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour chaque pays. De plus, la présence et la disponibilité des marques européennes et les difficultés rencontrées face à la concurrence forte ou faible des marques locales et nationales, l'impact des tarifs douaniers nationaux et les routes commerciales sont pris en compte lors de l'analyse prévisionnelle des données nationales.
Part de marché de la médecine vétérinaire en Europe
Le paysage concurrentiel du marché fournit des détails par concurrent. Il comprend la présentation de l'entreprise, ses données financières, son chiffre d'affaires, son potentiel de marché, ses investissements en recherche et développement, ses nouvelles initiatives commerciales, sa présence en Europe, ses sites et installations de production, ses capacités de production, ses forces et faiblesses, le lancement de nouveaux produits, leur ampleur et leur portée, ainsi que la domination de ses applications. Les données ci-dessus ne concernent que les activités des entreprises par rapport à leur marché.
Les leaders du marché européen de la médecine vétérinaire opérant sur le marché sont :
- Zoetis Services LLC (États-Unis)
- Merck & Co., Inc. (États-Unis)
- Elanco ou ses filiales (États-Unis)
- CH Boehringer Ingelheim International GmbH (Allemagne)
- IDEXX LABORATORIES, INC (Allemagne)
- AB Science (France)
- AdvaCare Pharma (États-Unis)
- ALMAX IMAGING srl (Italie)
- Anivive (États-Unis)
- BIOMÉRIEUX (France)
- Bionote USA Inc. (États-Unis)
- Bio-Rad Laboratories, Inc. (États-Unis)
- CANON MEDICAL SYSTEMS EUROPE BV (Japon)
- Cargill, Incorporated (États-Unis)
- Ceva (France)
- CureLab Oncologie (États-Unis)
- Dechra Pharmaceuticals Limited (Royaume-Uni)
- Demeditec Diagnostics GmbH (Allemagne)
- DHN International (États-Unis)
- Systèmes d'imagerie diagnostique (États-Unis)
- ESAOTE SPA (Italie)
- Eurofins Scientifique (Luxembourg)
- Evonik Industries AG (Allemagne)
- FUJIFILM Holdings Corporation (Japon)
- Diagnostics Gold Standard (États-Unis)
- Imagerie vétérinaire Hallmarq (Royaume-Uni)
- Hebei Veyong Pharmaceutical Co., Ltd. (Chine)
- Heska Corporation (États-Unis)
- IBIS SRL (Italie)
- Karyopharm (États-Unis)
- Meridian Bioscience, Inc. (États-Unis)
- Narang Medical Limited (Inde)
- Neogen Corporation (États-Unis)
- NIPPON ZENYAKU KOGYO CO., LTD. (Japon)
- Novavive Inc. (États-Unis)
- Nutreco (Pays-Bas)
- PLANMECA OY (Finlande)
- RINGPU BIOLOGY Co., Ltd. (Chine)
- Shenzhen SONTU Medical Imaging Equipment Co., Ltd (Chine)
- Thermo Fisher Scientific Inc. (États-Unis)
- Torigen Pharmaceuticals Inc. (États-Unis)
- VetDC (États-Unis)
- Vétoquinol (France)
- Virbac (France)
- VMRD, Inc. (États-Unis)
Derniers développements du marché européen de la médecine vétérinaire
- En février 2023, Vetoquinol lance Lygoferrin, un booster immunitaire naturel, formulé scientifiquement et conçu pour renforcer les mécanismes de défense des animaux. Ce produit innovant améliore la résistance aux infections en soutenant la réponse immunitaire innée de l'organisme. Lygoferrin contribue à réduire la dépendance aux antibiotiques, favorisant ainsi la santé et le bien-être général des animaux d'élevage et de compagnie. Sa formule avancée assure une absorption rapide et une protection efficace, minimisant ainsi le risque d'infections bactériennes et virales. Avec ce lancement, Vetoquinol renforce son engagement en faveur de solutions durables en santé animale, en offrant aux vétérinaires et aux éleveurs une alternative fiable et naturelle pour renforcer l'immunité et améliorer la productivité des soins animaliers.
- En février 2023, Vetoquinol lance Immun-C Aqua, un booster immunitaire hydrosoluble avancé conçu pour améliorer la santé et la résilience des espèces aquatiques. Cette formule innovante renforce la résistance aux maladies, améliore la vitalité globale et optimise les performances de croissance en pisciculture et en élevage de crevettes. En fortifiant le système immunitaire, Immun-C Aqua contribue à réduire la mortalité et à améliorer la survie dans des environnements difficiles. Sa composition scientifiquement élaborée garantit une absorption rapide et une action efficace, contribuant ainsi à une aquaculture durable et productive. Ce lancement souligne l'engagement de Vetoquinol à fournir des solutions de haute qualité, issues de la recherche, pour le secteur de l'aquaculture, favorisant ainsi la santé des animaux d'élevage et améliorant la rentabilité des exploitations.
- En janvier 2025, Laurie Hueneke Martens, vice-présidente associée des politiques publiques et des relations gouvernementales pour l'Europe chez Merck Animal Health, a reçu le 8e prix annuel « Une plume à son chapeau ». Reconnue pour son leadership en matière de politiques publiques et son accompagnement de futures dirigeantes, Mme Hueneke a également bénéficié d'un don de 5 000 USD aux associations caritatives pour la protection des animaux de son choix.
- En février 2024, Merck Santé Animale a annoncé que la Commission européenne avait accordé une autorisation de mise sur le marché à BRAVECTO TriUNO, un nouveau comprimé à croquer pour chiens. Ce produit cible les parasites internes et externes et offre une protection contre les puces, les tiques, les nématodes gastro-intestinaux, la dirofilariose et l'angiostrongylose. Il est désormais approuvé dans plusieurs pays, dont le Pérou et le Costa Rica.
- En novembre 2024, Merck Santé Animale a annoncé les lauréats du Prix de l'innovation porcine de haute qualité 2024. Romain Delcombel, de BioAZ, a remporté le titre de champion, suivi de Joao Lopes, de Redsoft Technologica LTDA, et de Jaap de Wit, de Westfort, troisième. Ces prix récompensent leurs contributions innovantes aux progrès de la filière porcine en matière de santé, de bien-être et de durabilité.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE VETERINARY MEDICINE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 DBMR MARKET POSITION GRID
2.8 MARKET END USER COVERAGE GRID
2.9 VENDOR SHARE ANALYSIS
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
4.3 PIPELINE ANALYSIS
4.4 TOP ENTITIES BASED ON R&D GLANCE FOR VETERINARY MEDICINE MARKET
4.5 EPIDEMIOLOGY
5 EUROPE VETERINARY MEDICINE MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PET OWNERSHIP BOOSTS DEMAND FOR VETERINARY SERVICES
6.1.2 RISING ANIMAL DISEASES DRIVE NEED FOR ADVANCED VETERINARY CARE
6.1.3 VETERINARY MEDICINE ADVANCES IMPROVE DIAGNOSIS AND TREATMENT OPTIONS
6.1.4 RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS INCREASES VETERINARY NEEDS
6.2 RESTRAINTS
6.2.1 HIGH VETERINARY CARE COSTS LIMIT MARKET ACCESSIBILITY
6.2.2 LACK OF AWARENESS ABOUT ANIMAL HEALTH LIMITS PROPER VETERINARY CARE ACCESS
6.3 OPPORTUNITIES
6.3.1 INCREASING NUMBER OF ANIMALS LEADING TO THE DEMAND OF VETERINARY MEDICINE
6.3.2 GROWTH IN ANIMAL HEALTH BIOTECHNOLOGY
6.3.3 GROWTH IN DEMAND FOR NUTRITIONAL SUPPLEMENTS
6.4 CHALLENGES
6.4.1 CHALLENGES OF REGULATORY COMPLIANCE AND COMPLEXITY
6.4.2 SHORTAGE OF VETERINARY PROFESSIONALS
7 EUROPE VETERINARY MEDICINE MARKET, BY TYPE
7.1 OVERVIEW
7.2 THERAPEUTICS
7.2.1 PHARMACEUTICALS
7.2.1.1 ANTIBIOTICS
7.2.1.1.1 TETRACYCLINE
7.2.1.1.2 PENICILLINS
7.2.1.1.3 MACROLIDES
7.2.1.1.4 AMINOGLYCOSIDES
7.2.1.1.5 LINCOSAMIDES
7.2.1.1.6 COLISTIN
7.2.1.1.7 OTHERS
7.2.1.2 PARASITICIDES
7.2.1.2.1 BENZIMIDAZOLES
7.2.1.2.2 MACROCYCLIC LACTONES
7.2.1.2.3 PYRETHROIDS
7.2.1.2.4 AMPROLIUM
7.2.1.2.5 NITROIMIDAZOLES
7.2.1.2.6 PIPERAZINE
7.2.1.2.7 OTHERS
7.2.1.3 ANALGESICS/ANTI-INFLAMMATORY (NSAIDS)
7.2.1.3.1 CARPROFEN
7.2.1.3.2 MELOXICAM
7.2.1.3.3 PHENYLBUTAZONE
7.2.1.3.4 ACETAMINOPHEN
7.2.1.3.5 FIROCOXIB
7.2.1.3.6 DERACOXIB
7.2.1.3.7 OTHERS
7.2.1.4 ANTIHISTAMINES
7.2.1.4.1 CETIRIZINE
7.2.1.4.2 BROMPHENIRAMINE
7.2.1.4.3 DIPHENHYDRAMINE
7.2.1.4.4 TERFENADINE
7.2.1.4.5 TRIMEPRAZINE
7.2.1.4.6 OTHERS
7.2.1.5 CORTICOSTEROIDS
7.2.1.5.1 DEXAMETHASONE
7.2.1.5.2 PREDNISOLONE
7.2.1.5.3 PREDNISONE
7.2.1.5.4 OTHERS
7.2.1.6 ANTIBLOAT
7.2.1.6.1 DOCUSATE
7.2.1.6.2 SIMETHICONE
7.2.1.6.3 OTHERS
7.2.1.7 HORMONAL
7.2.1.7.1 EQUINE CHORIONIC GONADOTROPIN
7.2.1.7.2 CLOPROSTENOL
7.2.1.7.3 OXYTOCIN
7.2.1.7.4 OTHERS
7.2.1.8 OPIOIDS
7.2.1.8.1 MU AGONISTS
7.2.1.8.1.1 METHADONE
7.2.1.8.1.2 MEPERIDINE
7.2.1.8.1.3 MORPHINE
7.2.1.8.1.4 OXYMORPHONE
7.2.1.8.1.5 OTHERS
7.2.1.8.2 PARTIAL MU AGONIST
7.2.1.8.2.1 BUPRENORPHINE
7.2.1.8.2.2 OTHERS
7.2.1.8.3 KAPPA AGONIST-MU ANTAGONIST
7.2.1.8.3.1 BUTORPHANOL
7.2.1.8.3.2 OTHERS
7.2.1.9 OTHERS
7.2.1.10 PHARMACEUTICALS BY DRUG TYPE
7.2.1.10.1 BRANDED
7.2.1.10.2 GENERIC
7.2.1.11 PHARMACEUTICALS BY PRESCRIPTION MODE
7.2.1.11.1 PRESCRIPTION BASED
7.2.1.11.2 OVER THE COUNTER
7.2.1.12 PHARMACEUTICALS BY ROUTE OF ADMINISTRATION,
7.2.1.12.1 ORAL
7.2.1.12.1.1 TABLETS
7.2.1.12.1.2 SOLUTIONS
7.2.1.12.1.3 POWDER
7.2.1.12.1.4 OTHERS
7.2.1.12.2 PARENTAL
7.2.1.12.2.1 INTRAVENOUS
7.2.1.12.2.2 SUBCUTANEOUS
7.2.1.12.2.3 OTHERS
7.2.1.12.3 TOPICAL
7.2.1.12.4 OTHERS
7.2.2 VACCINES
7.2.2.1 LIVE ATTENUATED VACCINES
7.2.2.2 TOXOID VACCINES
7.2.2.3 RECOMBINANT VACCINES
7.2.2.4 INACTIVATED VACCINES
7.2.2.5 OTHERS
7.2.3 BIOLOGICS
7.2.3.1 MARKETED
7.2.3.1.1 TOCERANIB
7.2.3.1.2 LOMUSTINE
7.2.3.1.3 CYCLOPHOSPHAMIDE
7.2.3.1.4 CHLORAMBUCIL
7.2.3.1.5 OTHERS
7.2.3.2 EMERGING
7.2.4 MEDICATED FEED ADDITIVES
7.2.4.1 ENZYMES
7.2.4.1.1 PHYTASE
7.2.4.1.2 CARBOHYDRASE
7.2.4.1.3 PROTEASE
7.2.4.1.4 AMYLASE
7.2.4.1.5 CELLULASE
7.2.4.1.6 MANNASE
7.2.4.1.7 GLUCANASE
7.2.4.1.8 XYLANASE
7.2.4.1.9 OTHERS
7.2.4.2 AMINO ACID
7.2.4.2.1 LYSINE
7.2.4.2.2 METHIONINE
7.2.4.2.3 THREONINE
7.2.4.2.4 TRYPTOPHAN
7.2.4.2.5 OTHERS
7.2.4.3 VITAMINS
7.2.4.3.1 FAT-SOLUBLE VITAMIN
7.2.4.3.1.1 VITAMIN A
7.2.4.3.1.2 VITAMIN E
7.2.4.3.1.3 VITAMIN D
7.2.4.3.1.4 VITAMIN K
7.2.4.3.2 WATER-SOLUBLE VITAMIN
7.2.4.3.2.1 VITAMIN B COMPLEX
7.2.4.3.2.2 VITAMIN C
7.2.4.4 ANTIOXIDANTS
7.2.4.4.1 BHA
7.2.4.4.2 BHT
7.2.4.4.3 ETHOXYQUIN
7.2.4.4.4 OTHERS
7.2.4.5 PROBIOTICS
7.2.4.6 LACTOBACILLI
7.2.4.7 BIFIDOBACTERIA
7.2.4.8 YEAST
7.2.4.9 STRETOCOCCUS THERMOPHILUS
7.2.4.10 FEED ACIDIFIERS
7.2.4.10.1 PROPIONIC ACID
7.2.4.10.2 FORMIC ACID
7.2.4.10.3 LACTIC ACID
7.2.4.10.4 CITRIC ACID
7.2.4.10.5 OTHERS
7.2.4.11 MYCOTOXIN DETOXIFIERS
7.2.4.11.1 MYCOTOXIN BINDERS
7.2.4.11.1.1 SILICATES
7.2.4.11.1.2 CLAYS
7.2.4.11.1.3 CHEMICAL POLYMERS
7.2.4.11.1.4 GLUCAN PRODUCTS
7.2.4.11.1.5 OTHERS
7.2.4.11.2 MYCOTOXIN MODIFIERS
7.2.4.12 PHYTOGENIC
7.2.4.12.1 ESSENTIAL OILS
7.2.4.12.2 HERBS & SPICES
7.2.4.12.3 OLEORESIN
7.2.4.12.4 OTHERS
7.2.4.13 CAROTENOIDS
7.2.4.13.1 BETA-CAROTENE
7.2.4.13.2 ASTAXANTHIN
7.2.4.13.3 LUTEIN
7.2.4.13.4 CANTHAXANTHIN
7.2.4.14 TRACE MINERALS
7.2.4.14.1 ZINC
7.2.4.14.2 COPPER
7.2.4.14.3 MANGANESE
7.2.4.14.4 IRON
7.2.4.14.5 SELENIUM
7.2.4.14.6 OTHERS
7.2.4.15 PRESERVATIVES
7.2.4.15.1 ANTICAKING AGENTS
7.2.4.15.2 MOLD INHIBITORS
7.2.4.16 FLAVOURS AND SWEETENERS
7.2.4.16.1 FLAVORS
7.2.4.16.2 SWEETENERS
7.2.4.16.2.1 SACCHARIN
7.2.4.16.2.2 NEOHESPERIDIN DIHYDROCHALCONE
7.2.4.16.2.3 GLYCYRRHIZIN
7.2.4.16.2.4 THAUMATIN
7.2.4.16.2.5 OTHERS
7.2.4.17 OTHERS
7.3 DIAGNOSTICS
7.3.1 INSTRUMENTS & DEVICES
7.3.1.1 IMAGING DEVICES
7.3.1.2 X-RAY IMAGING (RADIOGRAPHY)
7.3.1.2.1 SMALL ANIMALS
7.3.1.2.2 LARGE ANIMALS
7.3.1.3 ULTRASOUND
7.3.1.3.1 SMALL ANIMALS
7.3.1.3.2 LARGE ANIMALS
7.3.1.4 COMPUTED TOMOGRAPHY
7.3.1.4.1 SMALL ANIMALS
7.3.1.4.2 LARGE ANIMALS
7.3.1.5 MAGNETIC RESONANCE IMAGING
7.3.1.5.1 SMALL ANIMALS
7.3.1.5.2 LARGE ANIMALS
7.3.1.6 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)
7.3.1.6.1 SMALL ANIMALS
7.3.1.6.2 LARGE ANIMALS
7.3.1.6.3 OTHERS
7.3.2 LABORATORY INSTRUMENTS
7.3.2.1 HEMATOLOGY ANALYZERS
7.3.2.1.1 BY MODE
7.3.2.1.1.1 AUTOMATIC
7.3.2.1.1.2 SEMI-AUTOMATIC
7.3.2.1.2 BY PRICE RANGE
7.3.2.1.2.1 HIGH PRICE RANGE
7.3.2.1.2.2 STANDARD PRICE RANGE
7.3.2.1.3 BY MODALITY,
7.3.2.1.3.1 BENCHTOP
7.3.2.1.3.2 PORTABLE
7.3.2.1.3.3 OTHERS
7.3.2.2 CHEMISTRY ANALYZERS
7.3.2.2.1 BY MODE
7.3.2.2.1.1 AUTOMATIC
7.3.2.2.1.2 SEMI-AUTOMATIC
7.3.2.2.2 BY MODALITY,
7.3.2.2.2.1 BENCHTOP
7.3.2.2.2.2 PORTABLE
7.3.2.2.3 BY SAMPLE TYPE,
7.3.2.2.3.1 BLOOD
7.3.2.2.3.2 URINE
7.3.2.2.3.3 STOOL
7.3.2.2.3.4 OTHERS
7.3.2.3 POINT-OF-CARE INSTRUMENTS
7.3.2.3.1 BY TYPE
7.3.2.3.1.1 LATERAL FLOW POCT
7.3.2.3.1.2 MOLECULAR POCT
7.3.2.3.1.3 OTHERS
7.3.2.3.2 BY MODE
7.3.2.3.2.1 AUTOMATIC
7.3.2.3.2.2 SEMI-AUTOMATIC
7.3.2.4 COAGULATION ANALYZERS
7.3.2.4.1 BY CHANNEL,
7.3.2.4.1.1.1 4-CHANNEL
7.3.2.4.1.1.2 1-CHANNEL
7.3.2.4.2 BY SAMPLE TYPE
7.3.2.4.2.1 WHOLE BLOOD
7.3.2.4.2.2 PLASMA
7.3.2.4.3 BY MODALITY,
7.3.2.4.3.1 BENCHTOP
7.3.2.4.3.2 PORTABLE
7.3.2.5 URINALYSIS EQUIPMENT
7.3.2.5.1 BY MODE
7.3.2.5.1.1 AUTOMATIC
7.3.2.5.1.2 SEMI-AUTOMATIC
7.3.2.6 REFRACTOMETER
7.3.2.6.1 BY MODE,
7.3.2.6.1.1 OPTICAL
7.3.2.6.1.2 DIGITAL
7.3.2.6.2 BY MODALITY,
7.3.2.6.2.1 BENCHTOP
7.3.2.6.2.2 PORTABLE
7.3.2.7 OTHERS
7.3.3 REAGENTS & CONSUMABLES
7.3.3.1 KITS
7.3.3.1.1 PCR KITS
7.3.3.1.2 RAPID TEST KITS
7.3.3.1.3 MULTIPLEX KITS
7.3.3.1.4 ELISA KITS
7.3.3.1.5 SAMPLE PREPARATION KITS ISOLATION AND EXTRACTION KITS
7.3.3.1.6 OTHERS
7.3.3.2 REAGENTS
7.3.3.2.1 NUCLEIC ACID EXTRACTION REAGENTS
7.3.3.2.2 IMMUNOFLUORESCENCE REAGENTS
7.3.3.2.3 COOMBS REAGENTS
7.3.3.2.4 OTHERS REAGENTS
7.3.4 MEDIA
7.3.5 PANEL
7.3.6 STRIPS
7.3.7 CASSETTE
7.3.8 CONTROL STANDARDS
7.3.9 PROBES AND PRIMER
7.3.10 OTHERS CONSUMABLE AND ACCESSORIES
8 EUROPE VETERINARY MEDICINE MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 BACTERIAL DISEASES
8.2.1 PRODUCTION ANIMALS
8.2.2 COMPANION ANIMALS
8.3 CANINE ATOPIC DERMATITIS
8.3.1 COMPANION ANIMALS
8.3.2 PRODUCTION ANIMALS
8.4 HEMINTHES INFECTION
8.4.1 PRODUCTION ANIMALS
8.4.2 COMPANION ANIMALS
8.5 ANIMAL CANCER
8.5.1 COMPANION ANIMALS
8.5.2 PRODUCTION ANIMALS
8.6 FOOT AND MOUTH DISEASE
8.6.1 PRODUCTION ANIMALS
8.6.2 COMPANION ANIMALS
8.7 AUTOIMMUNE DISEASES
8.7.1 COMPANION ANIMALS
8.7.2 PRODUCTION ANIMALS
8.8 BLUETONGUE
8.8.1 PRODUCTION ANIMALS
8.8.2 COMPANION ANIMALS
8.9 OTHERS
8.9.1 COMPANION ANIMALS
8.9.2 PRODUCTION ANIMAL
9 EUROPE VETERINARY MEDICINE MARKET, BY ANIMAL TYPE
9.1 OVERVIEW
9.2 COMPANION ANIMALS
9.2.1 DOGS
9.2.2 CATS
9.2.3 HORSES
9.2.4 OTHERS
9.3 PRODUCTION ANIMAL
9.3.1 POULTRY
9.3.2 CATTLE
9.3.3 SWINE
9.3.4 FISH
9.3.5 SHEEP & GOATS
9.3.6 OTHERS
10 EUROPE VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 RETAIL SALES
10.2.1 OFFLINE
10.2.1.1 HOSPITAL PHARMACY
10.2.1.2 RETAIL PHARMACY
10.2.2 ONLINE
10.2.2.1 E-COMMERCE PLATFORMS
10.2.2.2 COMPANY WEBSITE
10.2.2.3 OTHERS
10.3 DIRECT TENDER
10.4 OTHERS
11 EUROPE VETERINARY MEDICINE MARKET, BY END USER
11.1 OVERVIEW
11.2 VETERINARY HOSPITALS
11.2.1 PRIVATE
11.2.2 PUBLIC
11.2.3 VETERINARY HOSPITALS BY LEVEL
11.2.3.1 TIER 2
11.2.3.2 TIER 1
11.2.3.3 TIER 3
11.3 VETERINARY CLINICS
11.3.1 VETERINARY CLINICS BY TYPE
11.3.1.1 PUBLIC
11.3.1.2 PRIVATE
11.4 ANIMAL AND VETERINARY FARMS
11.5 REFERENCE LABORATORIES
11.6 ACADEMIC AND RESEARCH INSTITUTE
11.7 POINT-OF-CARE TESTING/IN-HOUSE TESTING
11.8 OTHERS
12 EUROPE VETERINARY MEDICINE MARKET, BY REGION
12.1 EUROPE
12.1.1 GERMANY
12.1.2 FRANCE
12.1.3 U.K.
12.1.4 ITALY
12.1.5 SPAIN
12.1.6 RUSSIA
12.1.7 TURKEY
12.1.8 NETHERLANDS
12.1.9 SWITZERLAND
12.1.10 BELGIUM
12.1.11 REST OF EUROPE
13 EUROPE VETERINARY MEDICINE MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 ZOETIS SERVICES LLC SERVICES LLC.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.2 MERCK KGAA
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 ELANCO OR ITS AFFILIATES. OR ITS AFFILIATES
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
15.4.1 COMPANY SNAPSHOT
15.4.2 COMPANY SHARE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENT
15.5 IDEXX LABORATORIES, INC
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 AB SCIENCE
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 ADVACARE PHARMA
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 ALMAX IMAGING SRL
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 ANIVIVE
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 BIOMÉRIEUX
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 BIONOTE USA INC.
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 BIO-RAD LABORATORIES, INC.
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENT
15.13 CANON MEDICAL SYSTEMS EUROPE B.V.
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENT
15.14 CARGIL INCORPORATED
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 CEVA
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 CURELAB ONCOLOGY
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 DECHRA PHARMACEUTICALS LIMITED
15.17.1 COMPANY SNAPSHOT
15.17.2 REVENUE ANALYSIS
15.17.3 PRODUCT PORTFOLIO
15.17.4 RECENT DEVELOPMENT
15.18 DEMEDITEC DIAGNOSTICS GMBH
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENT
15.19 DHN
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENT
15.2 DIAGNOSTIC IMAGING SYSTEMS
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENT
15.21 ESAOTE SPA
15.21.1 COMPANY SNAPSHOT
15.21.2 PRODUCT PORTFOLIO
15.21.3 RECENT DEVELOPMENT
15.22 EUROFINS SCIENTIFIC
15.22.1 COMPANY SNAPSHOT
15.22.2 REVENUE ANALYSIS
15.22.3 PRODUCT PORTFOLIO
15.22.4 RECENT DEVELOPMENT
15.23 EVONIK ANIMAL NUTRITION
15.23.1 COMPANY SNAPSHOT
15.23.2 REVENUE ANALYSIS
15.23.3 1.1.3 PRODUCT PORTFOLIO
15.23.4 RECENT DEVELOPMENT
15.24 FUJIFILM HOLDINGS CORPORATION
15.24.1 COMPANY SNAPSHOT
15.24.2 REVENUE ANALYSIS
15.24.3 PRODUCT PORTFOLIO
15.24.4 RECENT DEVELOPMENT
15.25 GOLD STANDARD DIAGNOSTICS
15.25.1 COMPANY SNAPSHOT
15.25.2 PRODUCT PORTFOLIO
15.25.3 RECENT DEVELOPMENT
15.26 HALLMARQ VETERINARY IMAGING
15.26.1 COMPANY SNAPSHOT
15.26.2 PRODUCT PORTFOLIO
15.26.3 RECENT DEVELOPMENT
15.27 HEBEI VEYONG PHARMACEUTICAL CO., LTD.
15.27.1 COMPANY SNAPSHOT
15.27.2 PRODUCT PORTFOLIO
15.27.3 RECENT DEVELOPMENT
15.28 IBIS S.R.L.
15.28.1 COMPANY SNAPSHOT
15.28.2 PRODUCT PORTFOLIO
15.28.3 RECENT DEVELOPMENT
15.29 VIRBAC
15.29.1 COMPANY SNAPSHOT
15.29.2 REVENUE ANALYSIS
15.29.3 PRODUCT PORTFOLIO
15.29.4 RECENT DEVELOPMENT
15.3 VMRD, INC
15.30.1 COMPANY SNAPSHOT
15.30.2 PRODUCT PORTFOLIO
15.30.3 RECENT DEVELOPMENT
15.31 HESKA CORPORATION
15.31.1 COMPANY SNAPSHOT
15.31.2 REVENUE ANALYSIS
15.31.3 PRODUCT PORTFOLIO
15.31.4 RECENT DEVELOPMENT
15.32 KARYOPHARM
15.32.1 COMPANY SNAPSHOT
15.32.2 REVENUE ANALYSIS
15.32.3 PRODUCT PORTFOLIO
15.32.4 RECENT DEVELOPMENT
15.33 MERIDIAN BIOSCIENCE, INC
15.33.1 COMPANY SNAPSHOT
15.33.2 PRODUCT PORTFOLIO
15.33.3 RECENT DEVELOPMENT
15.34 NARANG MEDICAL LIMITED
15.34.1 COMPANY SNAPSHOT
15.34.2 PRODUCT PORTFOLIO
15.34.3 RECENT DEVELOPMENT
15.35 NEOGEN CORPORATION
15.35.1 COMPANY SNAPSHOT
15.35.2 REVENUE ANALYSIS
15.35.3 PRODUCT PORTFOLIO
15.35.4 RECENT DEVELOPMENT
15.36 NIPPON ZENYAKU KOGYO CO., LTD.
15.36.1 COMPANY SNAPSHOT
15.36.2 PRODUCT PORTFOLIO
15.36.3 RECENT DEVELOPMENT
15.37 VETDC
15.37.1 COMPANY SNAPSHOT
15.37.2 PRODUCT PORTFOLIO
15.37.3 RECENT DEVELOPMENT
15.38 NOVAVIVE INC.
15.38.1 COMPANY SNAPSHOT
15.38.2 PRODUCT PORTFOLIO
15.38.3 RECENT DEVELOPMENT
15.39 NUTRECO
15.39.1 COMPANY SNAPSHOT
15.39.2 PRODUCT PORTFOLIO
15.39.3 RECENT DEVELOPMENT
15.4 PLANMECA OY
15.40.1 COMPANY SNAPSHOT
15.40.2 PRODUCT PORTFOLIO
15.40.3 RECENT DEVELOPMENT
15.41 RANDOX LABORATORIES LTD.
15.41.1 COMPANY SNAPSHOT
15.41.2 PRODUCT PORTFOLIO
15.41.3 RECENT DEVELOPMENT
15.42 RINGPU BIOLOGY CO., LTD.
15.42.1 COMPANY SNAPSHOT
15.42.2 PRODUCT PORTFOLIO
15.42.3 RECENT DEVELOPMENT
15.43 SHENZHEN SONTU MEDICAL IMAGING EQUIPMENT CO., LTD
15.43.1 COMPANY SNAPSHOT
15.43.2 PRODUCT PORTFOLIO
15.43.3 RECENT DEVELOPMENT
15.44 THERMO FISHER SCIENTIFIC INC
15.44.1 COMPANY SNAPSHOT
15.44.2 REVENUE ANALYSIS
15.44.3 PRODUCT PORTFOLIO
15.44.4 RECENT DEVELOPMENT
15.45 TORIGEN PHARMACEUTICALS INC.
15.45.1 COMPANY SNAPSHOT
15.45.2 PRODUCT PORTFOLIO
15.45.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
Liste des tableaux
TABLE 1 EUROPE VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 2 EUROPE THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 3 EUROPE THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 4 EUROPE PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 5 EUROPE ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 6 EUROPE PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 7 EUROPE ANALGESICS/ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 8 EUROPE AANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 9 EUROPE CORTICOSTEROIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 10 EUROPE ANTIBLOAT IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 11 EUROPE HORMONAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 12 EUROPE OPIOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 13 EUROPE MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 14 EUROPE PARTIAL MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 15 EUROPE KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 16 EUROPE PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 17 EUROPE PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 18 EUROPE PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 19 EUROPE ORAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 20 EUROPE PARENTAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 21 EUROPE VACCINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 22 EUROPE BIOLOGICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 23 EUROPE MARKETED IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 24 EUROPE MEDICATED FEED ADDITIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 25 EUROPE ENZYMES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 26 EUROPE AMINO ACID IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 27 EUROPE VITAMINS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 28 EUROPE FAT-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 29 EUROPE WATER-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 30 EUROPE ANTIOXIDANTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 31 EUROPE PROBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 32 EUROPE FEED ACIDIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 33 EUROPE MYCOTOXIN DETOXIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 34 EUROPE MYCOTOXIN BINDERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 35 EUROPE PHYTOGENIC IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 36 EUROPE CAROTENOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 37 EUROPE TRACE MINERALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 38 EUROPE PRESERVATIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 39 EUROPE FLAVORS AND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 40 EUROPE SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 41 EUROPE DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 42 EUROPE DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 43 EUROPE INSTRUMENTS & DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 44 EUROPE IMAGING DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 45 EUROPE X-RAY IMAGING (RADIOGRAPHY) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 46 EUROPE ULTRASOUND IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 47 EUROPE COMPUTED TOMOGRAPHY IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 48 EUROPE MAGNETIC RESONANCE IMAGING IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 49 EUROPE SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 50 EUROPE LABORATORY INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 51 EUROPE HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 52 EUROPE HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY PRICE RANGE, 2018-2032 (USD THOUSAND)
TABLE 53 EUROPE HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 54 EUROPE CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 55 EUROPE CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 56 EUROPE CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 57 EUROPE POINT-OF-CARE INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 58 EUROPE COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 59 EUROPE COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 60 EUROPE COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 61 EUROPE COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 62 EUROPE URINALYSIS EQUIPMENT IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 63 EUROPE REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 64 EUROPE REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 65 EUROPE REAGENTS & CONSUMABLES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 66 EUROPE KITS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 67 EUROPE REAGENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 68 EUROPE VETERINARY MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 69 EUROPE BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 70 EUROPE BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 71 EUROPE CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 72 EUROPE CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 73 EUROPE HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 74 EUROPE HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 75 EUROPE ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 76 EUROPE ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 77 EUROPE FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 78 EUROPE FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 79 EUROPE AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 80 EUROPE AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 81 EUROPE BLUETONGUE IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 82 EUROPE BLUETONGUE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 83 EUROPE OTHERS IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 84 EUROPE OTHERS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 85 EUROPE VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 86 EUROPE COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 87 EUROPE COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 88 EUROPE PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 89 EUROPE PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 90 EUROPE VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 91 EUROPE RETAIL SALES IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 92 EUROPE RETAIL SALES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 93 EUROPE OFFLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 94 EUROPE ONLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 95 EUROPE DIRECT TENDER IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 96 EUROPE OTHERS IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 97 EUROPE VETERINARY MEDICINE MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 98 EUROPE VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 99 EUROPE VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 100 EUROPE VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 101 EUROPE VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 102 EUROPE VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 103 EUROPE ANIMAL AND VETERINARY FARMS IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 104 EUROPE REFERENCE LABORATORIES IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 105 EUROPE ACADEMIC AND RESEARCH INSTITUTE IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 106 EUROPE POINT-OF-CARE TESTING/IN-HOUSE TESTING IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 107 EUROPE OTHERS IN VETERINARY MEDICINE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 108 EUROPE VETERINARY MEDICINE MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 109 EUROPE VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 110 EUROPE THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 EUROPE PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 112 EUROPE ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 113 EUROPE PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 114 EUROPE ANALGESICS/ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 115 EUROPE ANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 116 EUROPE CORTICOSTEROIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 117 EUROPE ANTIBLOAT IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 118 EUROPE HORMONAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 119 EUROPE OPIOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 120 EUROPE MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 121 EUROPE PARTIAL MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 122 EUROPE KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 123 EUROPE PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 124 EUROPE PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 125 EUROPE PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 126 EUROPE ORAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 127 EUROPE PARENTAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 128 EUROPE VACCINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 129 EUROPE BIOLOGICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 130 EUROPE MARKETED IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 131 EUROPE MEDICATED FEED ADDITIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 132 EUROPE ENZYMES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 133 EUROPE AMINO ACID IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 134 EUROPE VITAMINS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 135 EUROPE FAT-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 136 EUROPE WATER-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 137 EUROPE ANTIOXIDANTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 138 EUROPE PROBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 139 EUROPE FEED ACIDIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 140 EUROPE MYCOTOXIN DETOXIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 141 EUROPE MYCOTOXIN BINDERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 142 EUROPE PHYTOGENIC IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 143 EUROPE CAROTENOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 144 EUROPE TRACE MINERALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 145 EUROPE PRESERVATIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 146 EUROPE FLAVORS AND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 147 EUROPE SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 148 EUROPE DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 149 EUROPE INSTRUMENTS & DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 150 EUROPE IMAGING DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 151 EUROPE X-RAY IMAGING (RADIOGRAPHY) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 152 EUROPE ULTRASOUND IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 153 EUROPE COMPUTED TOMOGRAPHY IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 154 EUROPE MAGNETIC RESONANCE IMAGING IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 155 EUROPE SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 156 EUROPE LABORATORY INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 157 EUROPE HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 158 EUROPE HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY PRICE RANGE, 2018-2032 (USD THOUSAND)
TABLE 159 EUROPE HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 160 EUROPE CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 161 EUROPE CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 162 EUROPE CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 163 EUROPE POINT-OF-CARE INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 164 EUROPE COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 165 EUROPE COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 166 EUROPE COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 167 EUROPE COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 168 EUROPE URINALYSIS EQUIPMENT IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 169 EUROPE REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 170 EUROPE REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 171 EUROPE REAGENTS & CONSUMABLES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 172 EUROPE KITS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 173 EUROPE REAGENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 174 EUROPE VETERINARY MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 175 EUROPE BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 176 EUROPE CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 177 EUROPE HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 178 EUROPE ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 179 EUROPE FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 180 EUROPE AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 181 EUROPE BLUETONGUE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 182 EUROPE OTHERS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 183 EUROPE VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 184 EUROPE COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 185 EUROPE PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 186 EUROPE VETERINARY MEDICINE MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 187 EUROPE VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 188 EUROPE VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 189 EUROPE VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 190 EUROPE VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 191 EUROPE RETAIL SALES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 192 EUROPE OFFLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 193 EUROPE ONLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 194 GERMANY VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 195 GERMANY THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 196 GERMANY PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 197 GERMANY ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 198 GERMANY PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 199 GERMANY ANALGESICS/ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 200 GERMANY ANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 201 GERMANY CORTICOSTEROIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 202 GERMANY ANTIBLOAT IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 203 GERMANY HORMONAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 204 GERMANY OPIOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 205 GERMANY MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 206 GERMANY PARTIAL MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 207 GERMANY KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 208 GERMANY PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 209 GERMANY PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 210 GERMANY PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 211 GERMANY ORAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 212 GERMANY PARENTAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 213 GERMANY VACCINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 214 GERMANY BIOLOGICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 215 GERMANY MARKETED IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 216 GERMANY MEDICATED FEED ADDITIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 217 GERMANY ENZYMES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 218 GERMANY AMINO ACID IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 219 GERMANY VITAMINS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 220 GERMANY FAT-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 221 GERMANY WATER-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 222 GERMANY ANTIOXIDANTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 223 GERMANY PROBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 224 GERMANY FEED ACIDIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 225 GERMANY MYCOTOXIN DETOXIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 226 GERMANY MYCOTOXIN BINDERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 227 GERMANY PHYTOGENIC IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 228 GERMANY CAROTENOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 229 GERMANY TRACE MINERALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 230 GERMANY PRESERVATIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 231 GERMANY FLAVORS AND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 232 GERMANY SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 233 GERMANY DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 234 GERMANY INSTRUMENTS & DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 235 GERMANY IMAGING DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 236 GERMANY X-RAY IMAGING (RADIOGRAPHY) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 237 GERMANY ULTRASOUND IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 238 GERMANY COMPUTED TOMOGRAPHY IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 239 GERMANY MAGNETIC RESONANCE IMAGING IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 240 GERMANY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 241 GERMANY LABORATORY INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 242 GERMANY HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 243 GERMANY HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY PRICE RANGE, 2018-2032 (USD THOUSAND)
TABLE 244 GERMANY HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 245 GERMANY CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 246 GERMANY CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 247 GERMANY CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 248 GERMANY POINT-OF-CARE INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 249 GERMANY COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 250 GERMANY COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 251 GERMANY COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 252 GERMANY COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 253 GERMANY URINALYSIS EQUIPMENT IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 254 GERMANY REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 255 GERMANY REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 256 GERMANY REAGENTS & CONSUMABLES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 257 GERMANY KITS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 258 GERMANY REAGENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 259 GERMANY VETERINARY MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 260 GERMANY BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 261 GERMANY CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 262 GERMANY HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 263 GERMANY ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 264 GERMANY FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 265 GERMANY AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 266 GERMANY BLUETONGUE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 267 GERMANY OTHERS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 268 GERMANY VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 269 GERMANY COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 270 GERMANY PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 271 GERMANY VETERINARY MEDICINE MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 272 GERMANY VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 273 GERMANY VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 274 GERMANY VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 275 GERMANY VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 276 GERMANY RETAIL SALES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 277 GERMANY OFFLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 278 GERMANY ONLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 279 FRANCE VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 280 FRANCE THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 281 FRANCE PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 282 FRANCE ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 283 FRANCE PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 284 FRANCE ANALGESICS/ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 285 FRANCE ANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 286 FRANCE CORTICOSTEROIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 287 FRANCE ANTIBLOAT IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 288 FRANCE HORMONAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 289 FRANCE OPIOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 290 FRANCE MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 291 FRANCE PARTIAL MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 292 FRANCE KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 293 FRANCE PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 294 FRANCE PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 295 FRANCE PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 296 FRANCE ORAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 297 FRANCE PARENTAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 298 FRANCE VACCINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 299 FRANCE BIOLOGICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 300 FRANCE MARKETED IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 301 FRANCE MEDICATED FEED ADDITIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 302 FRANCE ENZYMES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 303 FRANCE AMINO ACID IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 304 FRANCE VITAMINS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 305 FRANCE FAT-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 306 FRANCE WATER-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 307 FRANCE ANTIOXIDANTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 308 FRANCE PROBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 309 FRANCE FEED ACIDIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 310 FRANCE MYCOTOXIN DETOXIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 311 FRANCE MYCOTOXIN BINDERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 312 FRANCE PHYTOGENIC IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 313 FRANCE CAROTENOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 314 FRANCE TRACE MINERALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 315 FRANCE PRESERVATIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 316 FRANCE FLAVORS AND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 317 FRANCE SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 318 FRANCE DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 319 FRANCE INSTRUMENTS & DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 320 FRANCE IMAGING DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 321 FRANCE X-RAY IMAGING (RADIOGRAPHY) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 322 FRANCE ULTRASOUND IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 323 FRANCE COMPUTED TOMOGRAPHY IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 324 FRANCE MAGNETIC RESONANCE IMAGING IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 325 FRANCE SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 326 FRANCE LABORATORY INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 327 FRANCE HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 328 FRANCE HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY PRICE RANGE, 2018-2032 (USD THOUSAND)
TABLE 329 FRANCE HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 330 FRANCE CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 331 FRANCE CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 332 FRANCE CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 333 FRANCE POINT-OF-CARE INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 334 FRANCE COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 335 FRANCE COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 336 FRANCE COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 337 FRANCE COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 338 FRANCE URINALYSIS EQUIPMENT IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 339 FRANCE REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 340 FRANCE REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 341 FRANCE REAGENTS & CONSUMABLES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 342 FRANCE KITS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 343 FRANCE REAGENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 344 FRANCE VETERINARY MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 345 FRANCE BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 346 FRANCE CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 347 FRANCE HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 348 FRANCE ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 349 FRANCE FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 350 FRANCE AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 351 FRANCE BLUETONGUE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 352 FRANCE OTHERS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 353 FRANCE VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 354 FRANCE COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 355 FRANCE PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 356 FRANCE VETERINARY MEDICINE MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 357 FRANCE VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 358 FRANCE VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 359 FRANCE VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 360 FRANCE VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 361 FRANCE RETAIL SALES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 362 FRANCE OFFLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 363 FRANCE ONLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 364 U.K. VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 365 U.K. THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 366 U.K. PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 367 U.K. ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 368 U.K. PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 369 U.K. ANALGESICS/ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 370 U.K. ANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 371 U.K. CORTICOSTEROIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 372 U.K. ANTIBLOAT IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 373 U.K. HORMONAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 374 U.K. OPIOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 375 U.K. MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 376 U.K. PARTIAL MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 377 U.K. KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 378 U.K. PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 379 U.K. PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 380 U.K. PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 381 U.K. ORAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 382 U.K. PARENTAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 383 U.K. VACCINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 384 U.K. BIOLOGICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 385 U.K. MARKETED IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 386 U.K. MEDICATED FEED ADDITIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 387 U.K. ENZYMES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 388 U.K. AMINO ACID IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 389 U.K. VITAMINS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 390 U.K. FAT-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 391 U.K. WATER-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 392 U.K. ANTIOXIDANTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 393 U.K. PROBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 394 U.K. FEED ACIDIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 395 U.K. MYCOTOXIN DETOXIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 396 U.K. MYCOTOXIN BINDERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 397 U.K. PHYTOGENIC IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 398 U.K. CAROTENOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 399 U.K. TRACE MINERALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 400 U.K. PRESERVATIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 401 U.K. FLAVORS AND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 402 U.K. SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 403 U.K. DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 404 U.K. INSTRUMENTS & DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 405 U.K. IMAGING DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 406 U.K. X-RAY IMAGING (RADIOGRAPHY) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 407 U.K. ULTRASOUND IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 408 U.K. COMPUTED TOMOGRAPHY IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 409 U.K. MAGNETIC RESONANCE IMAGING IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 410 U.K. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 411 U.K. LABORATORY INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 412 U.K. HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 413 U.K. HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY PRICE RANGE, 2018-2032 (USD THOUSAND)
TABLE 414 U.K. HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 415 U.K. CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 416 U.K. CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 417 U.K. CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 418 U.K. POINT-OF-CARE INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 419 U.K. COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 420 U.K. COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 421 U.K. COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 422 U.K. COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 423 U.K. URINALYSIS EQUIPMENT IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 424 U.K. REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 425 U.K. REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 426 U.K. REAGENTS & CONSUMABLES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 427 U.K. KITS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 428 U.K. REAGENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 429 U.K. VETERINARY MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 430 U.K. BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 431 U.K. CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 432 U.K. HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 433 U.K. ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 434 U.K. FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 435 U.K. AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 436 U.K. BLUETONGUE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 437 U.K. OTHERS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 438 U.K. VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 439 U.K. COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 440 U.K. PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 441 U.K. VETERINARY MEDICINE MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 442 U.K. VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 443 U.K. VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 444 U.K. VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 445 U.K. VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 446 U.K. RETAIL SALES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 447 U.K. OFFLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 448 U.K. ONLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 449 ITALY VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 450 ITALY THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 451 ITALY PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 452 ITALY ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 453 ITALY PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 454 ITALY ANALGESICS/ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 455 ITALY ANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 456 ITALY CORTICOSTEROIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 457 ITALY ANTIBLOAT IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 458 ITALY HORMONAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 459 ITALY OPIOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 460 ITALY MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 461 ITALY PARTIAL MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 462 ITALY KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 463 ITALY PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 464 ITALY PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 465 ITALY PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 466 ITALY ORAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 467 ITALY PARENTAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 468 ITALY VACCINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 469 ITALY BIOLOGICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 470 ITALY MARKETED IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 471 ITALY MEDICATED FEED ADDITIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 472 ITALY ENZYMES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 473 ITALY AMINO ACID IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 474 ITALY VITAMINS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 475 ITALY FAT-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 476 ITALY WATER-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 477 ITALY ANTIOXIDANTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 478 ITALY PROBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 479 ITALY FEED ACIDIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 480 ITALY MYCOTOXIN DETOXIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 481 ITALY MYCOTOXIN BINDERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 482 ITALY PHYTOGENIC IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 483 ITALY CAROTENOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 484 ITALY TRACE MINERALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 485 ITALY PRESERVATIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 486 ITALY FLAVORS AND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 487 ITALY SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 488 ITALY DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 489 ITALY INSTRUMENTS & DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 490 ITALY IMAGING DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 491 ITALY X-RAY IMAGING (RADIOGRAPHY) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 492 ITALY ULTRASOUND IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 493 ITALY COMPUTED TOMOGRAPHY IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 494 ITALY MAGNETIC RESONANCE IMAGING IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 495 ITALY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 496 ITALY LABORATORY INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 497 ITALY HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 498 ITALY HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY PRICE RANGE, 2018-2032 (USD THOUSAND)
TABLE 499 ITALY HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 500 ITALY CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 501 ITALY CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 502 ITALY CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 503 ITALY POINT-OF-CARE INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 504 ITALY COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 505 ITALY COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 506 ITALY COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 507 ITALY COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 508 ITALY URINALYSIS EQUIPMENT IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 509 ITALY REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 510 ITALY REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 511 ITALY REAGENTS & CONSUMABLES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 512 ITALY KITS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 513 ITALY REAGENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 514 ITALY VETERINARY MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 515 ITALY BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 516 ITALY CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 517 ITALY HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 518 ITALY ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 519 ITALY FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 520 ITALY AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 521 ITALY BLUETONGUE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 522 ITALY OTHERS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 523 ITALY VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 524 ITALY COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 525 ITALY PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 526 ITALY VETERINARY MEDICINE MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 527 ITALY VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 528 ITALY VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 529 ITALY VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 530 ITALY VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 531 ITALY RETAIL SALES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 532 ITALY OFFLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 533 ITALY ONLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 534 SPAIN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 535 SPAIN THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 536 SPAIN PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 537 SPAIN ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 538 SPAIN PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 539 SPAIN ANLAGESICS/ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 540 SPAIN ANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 541 SPAIN CORTICOSTEROIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 542 SPAIN ANTIBLOAT IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 543 SPAIN HORMONAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 544 SPAIN OPIOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 545 SPAIN MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 546 SPAIN PARTIAL MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 547 SPAIN KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 548 SPAIN PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 549 SPAIN PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 550 SPAIN PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 551 SPAIN ORAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 552 SPAIN PARENTAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 553 SPAIN VACCINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 554 SPAIN BIOLOGICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 555 SPAIN MARKETED IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 556 SPAIN MEDICATED FEED ADDITIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 557 SPAIN ENZYMES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 558 SPAIN AMINO ACID IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 559 SPAIN VITAMINS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 560 SPAIN FAT-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 561 SPAIN WATER-SOLUBLE VITAMIN INVETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 562 SPAIN ANTIOXIDANTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 563 SPAIN PROBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 564 SPAIN FEED ACIDIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 565 SPAIN MYCOTOXIN DETOXIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 566 SPAIN MYCOTOXIN BINDERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 567 SPAIN PHYTOGENIC IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 568 SPAIN CAROTENOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 569 SPAIN TRACE MINERALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 570 SPAIN PRESERVATIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 571 SPAIN FLAVOURS AND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 572 SPAIN SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 573 SPAIN DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 574 SPAIN INSTRUMENTS & DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 575 SPAIN IMAGING DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 576 SPAIN X-RAY IMAGING (RADIOGRAPHY) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 577 SPAIN ULTRASOUND IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 578 SPAIN COMPUTED TOMOGRAPHY IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 579 SPAIN MAGNETIC RESONANCE IMAGING IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 580 SPAIN SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 581 SPAIN LABORATORY INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 582 SPAIN HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 583 SPAIN HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY PRICE RANGE, 2018-2032 (USD THOUSAND)
TABLE 584 SPAIN HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 585 SPAIN CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 586 SPAIN CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 587 SPAIN CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 588 SPAIN POINT-OF-CARE INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 589 SPAIN COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 590 SPAIN COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 591 SPAIN COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 592 SPAIN COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 593 SPAIN URINALYSIS EQUIPMENT IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 594 SPAIN REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 595 SPAIN REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 596 SPAIN REAGENTS & CONSUMABLES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 597 SPAIN KITS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 598 SPAIN REAGENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 599 SPAIN VETERINARY MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 600 SPAIN BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 601 SPAIN CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 602 SPAIN HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 603 SPAIN ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 604 SPAIN FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 605 SPAIN AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 606 SPAIN BLUETONGUE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 607 SPAIN OTHERS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 608 SPAIN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 609 SPAIN COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 610 SPAIN PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 611 SPAIN VETERINARY MEDICINE MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 612 SPAIN VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 613 SPAIN VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 614 SPAIN VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 615 SPAIN VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 616 SPAIN RETAIL SALES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 617 SPAIN OFFLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 618 SPAIN ONLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 619 RUSSIA VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 620 RUSSIA THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 621 RUSSIA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 622 RUSSIA ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 623 RUSSIA PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 624 RUSSIA ANLAGESICS/ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 625 RUSSIA ANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 626 RUSSIA CORTICOSTEROIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 627 RUSSIA ANTIBLOAT IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 628 RUSSIA HORMONAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 629 RUSSIA OPIOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 630 RUSSIA MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 631 RUSSIA PARTIAL MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 632 RUSSIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 633 RUSSIA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 634 RUSSIA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 635 RUSSIA PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 636 RUSSIA ORAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 637 RUSSIA PARENTAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 638 RUSSIA VACCINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 639 RUSSIA BIOLOGICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 640 RUSSIA MARKETED IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 641 RUSSIA MEDICATED FEED ADDITIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 642 RUSSIA ENZYMES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 643 RUSSIA AMINO ACID IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 644 RUSSIA VITAMINS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 645 RUSSIA FAT-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 646 RUSSIA WATER-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 647 RUSSIA ANTIOXIDANTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 648 RUSSIA PROBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 649 RUSSIA FEED ACIDIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 650 RUSSIA MYCOTOXIN DETOXIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 651 RUSSIA MYCOTOXIN BINDERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 652 RUSSIA PHYTOGENIC IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 653 RUSSIA CAROTENOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 654 RUSSIA TRACE MINERALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 655 RUSSIA PRESERVATIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 656 RUSSIA FLAVOURS AND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 657 RUSSIA SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 658 RUSSIA DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 659 RUSSIA INSTRUMENTS & DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 660 RUSSIA IMAGING DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 661 RUSSIA X-RAY IMAGING (RADIOGRAPHY) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 662 RUSSIA ULTRASOUND IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 663 RUSSIA COMPUTED TOMOGRAPHY IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 664 RUSSIA MAGNETIC RESONANCE IMAGING IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 665 RUSSIA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 666 RUSSIA LABORATORY INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 667 RUSSIA HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 668 RUSSIA HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY PRICE RANGE, 2018-2032 (USD THOUSAND)
TABLE 669 RUSSIA HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 670 RUSSIA CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 671 RUSSIA CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 672 RUSSIA CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 673 RUSSIA POINT-OF-CARE INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 674 RUSSIA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 675 RUSSIA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 676 RUSSIA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 677 RUSSIA COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 678 RUSSIA URINALYSIS EQUIPMENT IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 679 RUSSIA REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 680 RUSSIA REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 681 RUSSIA REAGENTS & CONSUMABLES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 682 RUSSIA KITS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 683 RUSSIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 684 RUSSIA BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 685 RUSSIA CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 686 RUSSIA HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 687 RUSSIA ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 688 RUSSIA FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 689 RUSSIA AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 690 RUSSIA BLUETONGUE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 691 RUSSIA OTHERS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 692 RUSSIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 693 RUSSIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 694 RUSSIA PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 695 RUSSIA VETERINARY MEDICINE MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 696 RUSSIA VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 697 RUSSIA VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 698 RUSSIA VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 699 RUSSIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 700 RUSSIA RETAIL SALES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 701 RUSSIA OFFLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 702 RUSSIA ONLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 703 TURKEY VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 704 TURKEY THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 705 TURKEY PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 706 TURKEY ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 707 TURKEY PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 708 TURKEY ANLAGESICS/ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 709 TURKEY ANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 710 TURKEY CORTICOSTEROIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 711 TURKEY ANTIBLOAT IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 712 TURKEY HORMONAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 713 TURKEY OPIOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 714 TURKEY MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 715 TURKEY PARTIAL MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 716 TURKEY KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 717 TURKEY PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 718 TURKEY PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 719 TURKEY PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 720 TURKEY ORAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 721 TURKEY PARENTAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 722 TURKEY VACCINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 723 TURKEY BIOLOGICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 724 TURKEY MARKETED IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 725 TURKEY MEDICATED FEED ADDITIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 726 TURKEY ENZYMES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 727 TURKEY AMINO ACID IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 728 TURKEY VITAMINS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 729 TURKEY FAT-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 730 TURKEY WATER-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 731 TURKEY ANTIOXIDANTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 732 TURKEY PROBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 733 TURKEY FEED ACIDIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 734 TURKEY MYCOTOXIN DETOXIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 735 TURKEY MYCOTOXIN BINDERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 736 TURKEY PHYTOGENIC IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 737 TURKEY CAROTENOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 738 TURKEY TRACE MINERALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 739 TURKEY PRESERVATIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 740 TURKEY FLAVOURS AND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 741 TURKEY SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 742 TURKEY DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 743 TURKEY INSTRUMENTS & DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 744 TURKEY IMAGING DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 745 TURKEY X-RAY IMAGING (RADIOGRAPHY) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 746 TURKEY ULTRASOUND IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 747 TURKEY COMPUTED TOMOGRAPHY IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 748 TURKEY MAGNETIC RESONANCE IMAGING IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 749 TURKEY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 750 TURKEY LABORATORY INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 751 TURKEY HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 752 TURKEY HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY PRICE RANGE, 2018-2032 (USD THOUSAND)
TABLE 753 TURKEY HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 754 TURKEY CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 755 TURKEY CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 756 TURKEY CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 757 TURKEY POINT-OF-CARE INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 758 TURKEY COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 759 TURKEY COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 760 TURKEY COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 761 TURKEY COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 762 TURKEY URINALYSIS EQUIPMENT IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 763 TURKEY REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 764 TURKEY REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 765 TURKEY REAGENTS & CONSUMABLES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 766 TURKEY KITS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 767 TURKEY REAGENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 768 TURKEY VETERINARY MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 769 TURKEY BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 770 TURKEY CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 771 TURKEY HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 772 TURKEY ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 773 TURKEY FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 774 TURKEY AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 775 TURKEY BLUETONGUE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 776 TURKEY OTHERS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 777 TURKEY VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 778 TURKEY COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 779 TURKEY PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 780 TURKEY VETERINARY MEDICINE MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 781 TURKEY VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 782 TURKEY VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 783 TURKEY VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 784 TURKEY VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 785 TURKEY RETAIL SALES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 786 TURKEY OFFLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 787 TURKEY ONLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 788 NETHERLANDS VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 789 NETHERLANDS THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 790 NETHERLANDS PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 791 NETHERLANDS ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 792 NETHERLANDS PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 793 NETHERLANDS ANLAGESICS/ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 794 NETHERLANDS ANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 795 NETHERLANDS CORTICOSTEROIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 796 NETHERLANDS ANTIBLOAT IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 797 NETHERLANDS HORMONAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 798 NETHERLANDS OPIOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 799 NETHERLANDS MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 800 NETHERLANDS PARTIAL MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 801 NETHERLANDS KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 802 NETHERLANDS PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 803 NETHERLANDS PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 804 NETHERLANDS PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 805 NETHERLANDS ORAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 806 NETHERLANDS PARENTAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 807 NETHERLANDS VACCINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 808 NETHERLANDS BIOLOGICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 809 NETHERLANDS MARKETED IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 810 NETHERLANDS MEDICATED FEED ADDITIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 811 NETHERLANDS ENZYMES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 812 NETHERLANDS AMINO ACID IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 813 NETHERLANDS VITAMINS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 814 NETHERLANDS FAT-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 815 NETHERLANDS WATER-SOLUBLE VITAMIN INVETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 816 NETHERLANDS ANTIOXIDANTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 817 NETHERLANDS PROBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 818 NETHERLANDS FEED ACIDIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 819 NETHERLANDS MYCOTOXIN DETOXIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 820 NETHERLANDS MYCOTOXIN BINDERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 821 NETHERLANDS PHYTOGENIC IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 822 NETHERLANDS CAROTENOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 823 NETHERLANDS TRACE MINERALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 824 NETHERLANDS PRESERVATIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 825 NETHERLANDS FLAVOURS AND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 826 NETHERLANDS SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 827 NETHERLANDS DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 828 NETHERLANDS INSTRUMENTS & DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 829 NETHERLANDS IMAGING DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 830 NETHERLANDS X-RAY IMAGING (RADIOGRAPHY) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 831 NETHERLANDS ULTRASOUND IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 832 NETHERLANDS COMPUTED TOMOGRAPHY IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 833 NETHERLANDS MAGNETIC RESONANCE IMAGING IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 834 NETHERLANDS SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 835 NETHERLANDS LABORATORY INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 836 NETHERLANDS HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 837 NETHERLANDS HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY PRICE RANGE, 2018-2032 (USD THOUSAND)
TABLE 838 NETHERLANDS HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 839 NETHERLANDS CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 840 NETHERLANDS CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 841 NETHERLANDS CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 842 NETHERLANDS POINT-OF-CARE INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 843 NETHERLANDS COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 844 NETHERLANDS COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 845 NETHERLANDS COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 846 NETHERLANDS COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 847 NETHERLANDS URINALYSIS EQUIPMENT IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 848 NETHERLANDS REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 849 NETHERLANDS REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 850 NETHERLANDS REAGENTS & CONSUMABLES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 851 NETHERLANDS KITS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 852 NETHERLANDS REAGENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 853 NETHERLANDS VETERINARY MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 854 NETHERLANDS BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 855 NETHERLANDS CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 856 NETHERLANDS HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 857 NETHERLANDS ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 858 NETHERLANDS FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 859 NETHERLANDS AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 860 NETHERLANDS BLUETONGUE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 861 NETHERLANDS OTHERS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 862 NETHERLANDS VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 863 NETHERLANDS COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 864 NETHERLANDS PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 865 NETHERLANDS VETERINARY MEDICINE MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 866 NETHERLANDS VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 867 NETHERLANDS VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 868 NETHERLANDS VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 869 NETHERLANDS VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 870 NETHERLANDS RETAIL SALES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 871 NETHERLANDS OFFLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 872 NETHERLANDS ONLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 873 SWITZERLAND VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 874 SWITZERLAND THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 875 SWITZERLAND PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 876 SWITZERLAND ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 877 SWITZERLAND PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 878 SWITZERLAND ANLAGESICS/ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 879 SWITZERLAND ANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 880 SWITZERLAND CORTICOSTEROIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 881 SWITZERLAND ANTIBLOAT IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 882 SWITZERLAND HORMONAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 883 SWITZERLAND OPIOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 884 SWITZERLAND MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 885 SWITZERLAND PARTIAL MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 886 SWITZERLAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 887 SWITZERLAND PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 888 SWITZERLAND PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 889 SWITZERLAND PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 890 SWITZERLAND ORAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 891 SWITZERLAND PARENTAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 892 SWITZERLAND VACCINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 893 SWITZERLAND BIOLOGICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 894 SWITZERLAND MARKETED IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 895 SWITZERLAND MEDICATED FEED ADDITIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 896 SWITZERLAND ENZYMES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 897 SWITZERLAND AMINO ACID IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 898 SWITZERLAND VITAMINS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 899 SWITZERLAND FAT-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 900 SWITZERLAND WATER-SOLUBLE VITAMIN INVETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 901 SWITZERLAND ANTIOXIDANTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 902 SWITZERLAND PROBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 903 SWITZERLAND FEED ACIDIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 904 SWITZERLAND MYCOTOXIN DETOXIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 905 SWITZERLAND MYCOTOXIN BINDERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 906 SWITZERLAND PHYTOGENIC IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 907 SWITZERLAND CAROTENOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 908 SWITZERLAND TRACE MINERALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 909 SWITZERLAND PRESERVATIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 910 SWITZERLAND FLAVOURS AND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 911 SWITZERLAND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 912 SWITZERLAND DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 913 SWITZERLAND INSTRUMENTS & DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 914 SWITZERLAND IMAGING DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 915 SWITZERLAND X-RAY IMAGING (RADIOGRAPHY) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 916 SWITZERLAND ULTRASOUND IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 917 SWITZERLAND COMPUTED TOMOGRAPHY IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 918 SWITZERLAND MAGNETIC RESONANCE IMAGING IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 919 SWITZERLAND SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 920 SWITZERLAND LABORATORY INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 921 SWITZERLAND HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 922 SWITZERLAND HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY PRICE RANGE, 2018-2032 (USD THOUSAND)
TABLE 923 SWITZERLAND HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 924 SWITZERLAND CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 925 SWITZERLAND CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 926 SWITZERLAND CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 927 SWITZERLAND POINT-OF-CARE INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 928 SWITZERLAND COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 929 SWITZERLAND COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 930 SWITZERLAND COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 931 SWITZERLAND COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 932 SWITZERLAND URINALYSIS EQUIPMENT IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 933 SWITZERLAND REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 934 SWITZERLAND REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 935 SWITZERLAND REAGENTS & CONSUMABLES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 936 SWITZERLAND KITS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 937 SWITZERLAND REAGENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 938 SWITZERLAND VETERINARY MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 939 SWITZERLAND BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 940 SWITZERLAND CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 941 SWITZERLAND HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 942 SWITZERLAND ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 943 SWITZERLAND FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 944 SWITZERLAND AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 945 SWITZERLAND BLUETONGUE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 946 SWITZERLAND OTHERS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 947 SWITZERLAND VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 948 SWITZERLAND COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 949 SWITZERLAND PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 950 SWITZERLAND VETERINARY MEDICINE MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 951 SWITZERLAND VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 952 SWITZERLAND VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 953 SWITZERLAND VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 954 SWITZERLAND VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 955 SWITZERLAND RETAIL SALES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 956 SWITZERLAND OFFLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 957 SWITZERLAND ONLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 958 BELGIUM VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 959 BELGIUM THERAPEUTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 960 BELGIUM PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 961 BELGIUM ANTIBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 962 BELGIUM PARASITICIDES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 963 BELGIUM ANLAGESICS/ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 964 BELGIUM ANTIHISTAMINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 965 BELGIUM CORTICOSTEROIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 966 BELGIUM ANTIBLOAT IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 967 BELGIUM HORMONAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 968 BELGIUM OPIOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 969 BELGIUM MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 970 BELGIUM PARTIAL MU AGONISTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 971 BELGIUM KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 972 BELGIUM PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 973 BELGIUM PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 974 BELGIUM PHARMACEUTICALS IN VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 975 BELGIUM ORAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 976 BELGIUM PARENTAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 977 BELGIUM VACCINES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 978 BELGIUM BIOLOGICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 979 BELGIUM MARKETED IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 980 BELGIUM MEDICATED FEED ADDITIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 981 BELGIUM ENZYMES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 982 BELGIUM AMINO ACID IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 983 BELGIUM VITAMINS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 984 BELGIUM FAT-SOLUBLE VITAMIN IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 985 BELGIUM WATER-SOLUBLE VITAMIN INVETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 986 BELGIUM ANTIOXIDANTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 987 BELGIUM PROBIOTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 988 BELGIUM FEED ACIDIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 989 BELGIUM MYCOTOXIN DETOXIFIERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 990 BELGIUM MYCOTOXIN BINDERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 991 BELGIUM PHYTOGENIC IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 992 BELGIUM CAROTENOIDS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 993 BELGIUM TRACE MINERALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 994 BELGIUM PRESERVATIVES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 995 BELGIUM FLAVOURS AND SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 996 BELGIUM SWEETENERS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 997 BELGIUM DIAGNOSTICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 998 BELGIUM INSTRUMENTS & DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 999 BELGIUM IMAGING DEVICES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 1000 BELGIUM X-RAY IMAGING (RADIOGRAPHY) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 1001 BELGIUM ULTRASOUND IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 1002 BELGIUM COMPUTED TOMOGRAPHY IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 1003 BELGIUM MAGNETIC RESONANCE IMAGING IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 1004 BELGIUM SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 1005 BELGIUM LABORATORY INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 1006 BELGIUM HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 1007 BELGIUM HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY PRICE RANGE, 2018-2032 (USD THOUSAND)
TABLE 1008 BELGIUM HEMATOLOGY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 1009 BELGIUM CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 1010 BELGIUM CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 1011 BELGIUM CHEMISTRY ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 1012 BELGIUM POINT-OF-CARE INSTRUMENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 1013 BELGIUM COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 1014 BELGIUM COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 1015 BELGIUM COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 1016 BELGIUM COAGULATION ANALYZERS IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 1017 BELGIUM URINALYSIS EQUIPMENT IN VETERINARY MEDICINE MARKET, BY MODE, 2018-2032 (USD THOUSAND)
TABLE 1018 BELGIUM REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 1019 BELGIUM REFRACTOMETER IN VETERINARY MEDICINE MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 1020 BELGIUM REAGENTS & CONSUMABLES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 1021 BELGIUM KITS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 1022 BELGIUM REAGENTS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 1023 BELGIUM VETERINARY MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 1024 BELGIUM BACTERIAL DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 1025 BELGIUM CANINE ATOPIC DERMATITIS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 1026 BELGIUM HEMINTHES INFECTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 1027 BELGIUM ANIMAL CANCER IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 1028 BELGIUM FOOT AND MOUTH DISEASE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 1029 BELGIUM AUTOIMMUNE DISEASES IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 1030 BELGIUM BLUETONGUE IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 1031 BELGIUM OTHERS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 1032 BELGIUM VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2018-2032 (USD THOUSAND)
TABLE 1033 BELGIUM COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 1034 BELGIUM PRODUCTION ANIMAL IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 1035 BELGIUM VETERINARY MEDICINE MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 1036 BELGIUM VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 1037 BELGIUM VETERINARY HOSPITALS IN VETERINARY MEDICINE MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 1038 BELGIUM VETERINARY CLINICS IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 1039 BELGIUM VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 1040 BELGIUM RETAIL SALES IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 1041 BELGIUM OFFLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 1042 BELGIUM ONLINE IN VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 1043 REST OF EUROPE VETERINARY MEDICINE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
Liste des figures
FIGURE 1 EUROPE VETERINARY MEDICINE MARKET: SEGMENTATION
FIGURE 2 EUROPE VETERINARY MEDICINE MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE VETERINARY MEDICINE MARKET: DROC ANALYSIS
FIGURE 4 EUROPE VETERINARY MEDICINE MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE VETERINARY MEDICINE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE VETERINARY MEDICINE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE VETERINARY MEDICINE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE VETERINARY MEDICINE MARKET: END USER COVERAGE GRID
FIGURE 9 EUROPE VETERINARY MEDICINE MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE VETERINARY MEDICINE MARKET: SEGMENTATION
FIGURE 11 NORTH AMERICA IS EXPECTED TO DOMINATE THE EUROPE VETERINARY MEDICINE MARKET AND ASIA PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 12 TWO SEGMENTS COMPRISE THE EUROPE VETERINARY MEDICINE MARKET, BY TYPE
FIGURE 13 EXECUTIVE SUMMARY
FIGURE 14 STRATEGIC DECISIONS
FIGURE 15 INCREASING PET OWNERSHIP BOOSTS DEMAND FOR VETERINARY SERVICES IS DRIVING THE GROWTH OF THE EUROPE VETERINARY MEDICINE MARKET FROM 2025 TO 2032
FIGURE 16 THERAPEUTIC SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE VETERINARY MEDICINE MARKET IN 2025 AND 2032
FIGURE 17 ASIA PACIFIC IS THE FASTEST GROWING REGION FOR THE EUROPE VETERINARY MEDICINE MARKET IN 2025 & 2032
FIGURE 18 DROC ANALYSIS
FIGURE 19 EUROPE VETERINARY MEDICINE MARKET: BY TYPE, 2024
FIGURE 20 EUROPE VETERINARY MEDICINE MARKET: BY TYPE, 2025 2032 (USD THOUSAND)
FIGURE 21 EUROPE VETERINARY MEDICINE MARKET: BY TYPE, CAGR (2025 2032)
FIGURE 22 EUROPE VETERINARY MEDICINE MARKET: BY TYPE, LIFELINE CURVE
FIGURE 23 EUROPE VETERINARY MEDICINE MARKET: BY APPLICATION, 2024
FIGURE 24 EUROPE VETERINARY MEDICINE MARKET: BY APPLICATION, 2025 2032 (USD THOUSAND)
FIGURE 25 EUROPE VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2025 2032)
FIGURE 26 EUROPE VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 27 EUROPE VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2024
FIGURE 28 EUROPE VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2025 2032 (USD THOUSAND)
FIGURE 29 EUROPE VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2025 2032)
FIGURE 30 EUROPE VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 31 EUROPE VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2024
FIGURE 32 EUROPE VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2025 2032 (USD THOUSAND)
FIGURE 33 EUROPE VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025 2032)
FIGURE 34 EUROPE VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 35 EUROPE VETERINARY MEDICINE MARKET: BY END USER, 2024
FIGURE 36 EUROPE VETERINARY MEDICINE MARKET: BY END USER, 2025 2032 (USD THOUSAND)
FIGURE 37 EUROPE VETERINARY MEDICINE MARKET: BY END USER, CAGR (2025 2032)
FIGURE 38 EUROPE VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 39 EUROPE VETERINARY MEDICINE MARKET: SNAPSHOT (2024)
FIGURE 40 EUROPE VETERINARY MEDICINE MARKET: COMPANY SHARE 2024 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
